Stockwinners Market Radar for November 21, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
NURO | Hot Stocks19:50 EST NeuroMetrix trading halted, news pending
|
JACK | Hot Stocks19:23 EST Jack in the Box signed 123 new restaurant commitments in 2023 - Jack in the Box announced that it signed 123 new restaurant commitments during its 2023 fiscal year. The brand also announced the signing of 138 new restaurant commitments for Del Taco. The news comes as the company announced its Q4 and fiscal year 2023 financial results. Jack in the Box continues its momentum in 2023 by announcing market entry into four new states: Arkansas, Florida, Montana, and Wyoming. The brand also signed a 22-unit commitment to enter Mexico. In mid-2023, Jack in the Box set a record for a restaurant opening in a new market, surpassing the previous revenue mark by 66% with its first opening in Salt Lake City. The brand continued its growth into whitespace territory with its first opening in Kentucky and announced the signing of a six-unit commitment in the Louisville market with a 55-year veteran Jack in the Box franchise group. "The response in new markets, for both brands, has continued to exceed our expectations," said Tim Linderman, chief development officer. "We have developed a strong playbook for how to best open and sustain new market entry, and franchisees interested in partnering with our iconic brands have recognized the potential for whitespace growth and backfilling our current markets. We've been on an incredible roll since our development program started in 2021, and our 2023 results demonstrated that our momentum has continued."
|
SBUX | Hot Stocks19:22 EST Starbucks says will review SOC's proposed director nominees - Starbucks that it has received a notice of nomination by Strategic Organizing Center Investment Group of three director candidates for election to the Starbucks Board of Directors at its 2024 Annual Meeting of Shareholders. The Company issued the following statement: "The Starbucks Board and executive leadership team regularly engage with all stakeholders, and we are committed to constructive dialogue that furthers our collective goal of creating long-term value for all stakeholders. Since its founding, Starbucks has been committed to a process of continuous improvement and transformation at all levels and has consistently sought to create opportunities for its partners. That continues today through our ongoing dialogue with our partners, as well as all of our stakeholders. As the world has emerged from the COVID-19 pandemic, the Board and leadership team have evolved to meet the needs of a new era. A year ago, the Board brought in Laxman Narasimhan as the ceo of Starbucks through a unique six-month immersion leading up to a refounding of the company. Earlier this month, Narasimhan launched a new mission that puts our partners at the center of our purpose... Over the past three years, we have deepened our commitment to this approach and invested nearly $9 billion to uplift the overall partner and store experience, with more than one third of that investment going directly to the partners through wage increases, training, new innovative equipment and technology. This represents the reinvestment of an average of nearly 20% of Starbucks fiscal year profits back into the partner experience with that level of investment expected to continue in fiscal year 2024. These investments have led to a more consistent partner experience in company-operated stores across the U.S. Coupled with higher wages and the expansion of hours, these investments have not only resulted in lower turnover - which is now below pre-pandemic levels - but we have also increased hourly total cash compensation by nearly 50% since fiscal year 2020. The Board's Nominating and Corporate Governance Committee will review SOC Investment Group's proposed director nominee[s] in accordance with its normal process, and the Board will present its formal recommendation regarding director nominees in the Company's proxy statement and other materials to be filed with the Securities and Exchange Commission. Starbucks shareholders are not required to take any action at this time."
|
TSLA | Hot Stocks18:43 EST Tesla cuts Model Y inventory prices - According to its inventory webpage, Tesla has lowered the price of its Model Y vehicles. The Model Y Long Range Dual Motor All-Wheel Drive now lists at $47,030, down from $48,990, according to the site. Reference Link
|
MESO | Hot Stocks18:34 EST Mesoblast partners with BMT CTN - Mesoblast announced that the Blood and Marrow Transplant Clinical Trials Network, a body including centers responsible for approximately 80% of all U.S. allogeneic BMTs, has entered into an agreement to develop a pivotal trial of Mesoblast's lead product candidate Ryoncil in the treatment of adults with steroid-refractory acute graft versus host disease. The BMT CTN is funded by the United States National Institutes of Health.
|
HPQ | Hot Stocks18:23 EST HP Inc. CEO: The PC market has started to recover - In an interview on CNBC's Mad Money, Enrique Lores said he expects the PC market to grow in 2024 as the transition to Windows 11 accelerates. He expects the introduction of AI into PCs by the end of 2024. He sees tremendous growth in the industrial printing segment. The company now has more than 13M printing subscribers. "The vision is to be able to offer our whole portfolio as a subscription," he added.
|
SENEB | Hot Stocks18:09 EST Seneca Foods announces voluntary recalled of mislabeled Hy-Vee Turkey gravy - As a precautionary measure, Seneca Foods is announcing a voluntary recall of mislabeled Hy-Vee Turkey gravy in glass jars that actually contains beef gravy. This product could potentially contain a soy allergen which is not declared on the label. Seneca is now retrieving improperly labeled Hy-Vee Turkey Gravy from its distribution system. This recall only affects Hy-Vee Turkey Gravy product sold by Hy-Vee. No other retailers are affected. People who have an allergy or severe sensitivity to soy run the risk of serious or life-threatening allergic reaction if they consume these products.
|
URBN | Hot Stocks17:34 EST Urban Outfitters says Urban Outfitters brand inventory levels elevated - Says levels elevated versus "where we would like them to be." Says inventory levels will lead to higher markdowns than originally planned during the holiday season for the brand. Comments taken from Q3 earnings conference call.
|
MSFT | Hot Stocks17:30 EST User reports indicate problems at OpenAI, Downdetector says - Reference Link
|
NVDA | Hot Stocks17:24 EST Nvidia says expects strong sequential growth to be driven by data center - Says experienced record data center revenue in the quarter. Says inferencing is contributing significantly to data center demand. Says significantly improved supply each quarter. Says sales to destinations affected by export restrictions to decline significantly in Q4. Says UK government announced it will build one of the most powerful Ai supercomputer. Comments taken from Q3 earnings conference call.
|
AAPL | Hot Stocks17:04 EST Apple CEO Tim Cook would want successor to be from within, Apple Insider says - It is generally assumed that iphone maker, Apple, known for keeping its succession plans to itself, will pick a successor for CEO Tim Cook from within the company, William Gallagher wrote for Apple Insider. In an interview with podcast "Dua Lipa: At Your Service," produced by BBC, the Apple CEO, responded to questions on succession plans by confirming that he would want the candidate to be picked from within and his job is to ensure several names "for the board to pick from," added the AI story. Reference Link
|
GBNH | Hot Stocks17:03 EST Greenbrook TMS announces settlement agreement of ongoing litigation - Greenbrook TMS announced that the Company has entered into a settlement agreement with the plaintiff regarding the previously-announced breach of contract claim in connection with an approximately $2M promissory note that was issued to a lender associated with Benjamin Klein, a seller of Check Five, doing business as "Success TMS", that the Company acquired in July 2022. Under the terms of the settlement agreement, the Company will make payments to the plaintiff in the total amount of approximately $2.2M, structured as an initial immediate payment of $250,000, weekly payments of $75,000 thereafter up to and until the May 1, 2024 maturity date of the promissory note, upon which the balance owing will be due. In exchange for entry into the settlement agreement, the plaintiffs will immediately dismiss, with prejudice, the Klein Note Action and both parties will provide a mutual release of claims. Contemporaneous with, but not included in the settlement agreement, the parties have also agreed to stay the separate complaint concerning alleged disputes arising out of the purchase agreement for the acquisition of Success TMS and other related matters for up to six months, subject to court approval. Benjamin Klein, a seller of Success TMS and a plaintiff in the Klein Matters, is a former director and a significant shareholder of Greenbrook. Klein was also the COO of Greenbrook from July 2022 until his termination by the Company effective May 4, 2023.
|
ACAD | Hot Stocks17:02 EST Acadia Pharmaceuticals head of R&D, Doug Williamson, M.D., to leave - Acadia Pharmaceuticals announced that Doug Williamson, M.D., Executive Vice President, Head of Research and Development, will be leaving the company to pursue other opportunities. Dr. Williamson joined Acadia in January 2023 and will continue in his role during a transitional period. The company has initiated a search for his replacement.
|
SF | Hot Stocks16:39 EST Stifel says total client assets down 2% for October-end from last month - Stifel Financial reported selected operating results for October 31, in an effort to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed. Ronald J. Kruszewski, Chairman and Chief Executive Officer, said, "Total client and fee-based assets declined from the prior month's levels due primarily to lower equity markets despite continued strength in recruiting. Client money market and insured product balances decreased 1% as growth in Smart Rate Balances was offset by declines in Sweep Balances. Overall, total client cash levels increased modestly from September due to growth in money market funds and short-term treasury balances."
|
AL... | Hot Stocks16:34 EST Air Lease announces delivery of 25 Boeing 737-8 jets to Malaysia Airlines Berhad - Air Lease (AL) announced the first of 25 new Boeing (BA) 737-8 aircraft delivered to Malaysia Airlines Berhad from ALC's order book with Boeing. Featuring CFM LEAP 1B-27 engines, this new Boeing aircraft is the first 737-8 addition to Malaysia Airlines' fleet. "We are thrilled to announce ALC's first of 25 new Boeing 737-8 aircraft delivered to Malaysia Airlines," said Steven Udvar-Hazy, Executive Chairman of Air Lease Corporation. "Our significant deal for 25 new Boeing 737-8 aircraft with MAB is a milestone transaction that demonstrates ALC's commitment to the national carrier's long-term fleet modernization and sustainability program. We are honored to be the first to introduce the 737-8 to the airline." This Boeing 737 aircraft joins six Airbus (EADSY) A350-900 aircraft currently on long-term lease to the airline from ALC.
|
CRM | Hot Stocks16:34 EST Salesforce shifts Q3 results release to November 29 - Salesforce announced that its Q3 results will now be released on Wednesday, November 29, after the close of the market, instead of Thursday, November 30, to accommodate executive schedules. The company will host a conference call at 5:00 pm ET to discuss its financial results with the investment community.
|
SONX | Hot Stocks16:34 EST Sonendo announces suspension of NYSE trading - Sonendo announced that, on November 15, 2023, it received a notice from the New York Stock Exchange that the Company was no longer in compliance with the NYSE continued listing standards set forth in Section 802.01B of the NYSE's Listed Company Manual due to the Company's average global market capitalization over a consecutive 30 trading-day period being less than $50 million and its stockholders' equity being less than $50 million. As set forth in the notice, as of November 14, 2023, the 30 trading-day average global market capitalization of the Company was approximately $15.5 million and the Company's last reported stockholders' equity as of September 30, 2023 was approximately $37.8 million. The Company has notified the NYSE that it intends to submit a plan to regain compliance within 45 days of the notice received on November 15, 2023 advising the NYSE of definitive action it has or will take to regain compliance. If the NYSE accepts the Company's plan, the Company's common stock, par value $0.001 per share, may continue to be listed and traded on the NYSE during the 18-month cure period, subject to the Company's pending NYSE appeal and hearing determination.
|
CAAP | Hot Stocks16:33 EST Corporacion America Airport reports October passenger traffic up 14.5% y/y - Corporacion America Airports reported a 14.5% year-on-year increase in passenger traffic in October 2023, surpassing October 2019 levels by 1.2%. Total passenger traffic grew 14.5% compared to the same month of 2022, supported by the ongoing recovery in travel demand after the Covid-19 pandemic and the gradual resumption of routes and frequencies across all countries of operations. Overall passenger traffic reached 101.2% of October 2019 levels, up from the 98.9% posted in September, with all countries except Brazil above pre-pandemic. International passenger traffic surpassed pre-pandemic levels of October 2019 by 8.8%, while domestic traffic also improved versus the prior month slightly exceeding October 2019 levels.
|
RIO | Hot Stocks16:32 EST Rio Tinto reaches settlement with SEC over RTCM impairment disclosure - Rio Tinto said it has reached a court approved settlement with the Securities and Exchange Commission of a suit brought in 2017 concerning disclosure of the impairment of Rio Tinto Coal Mozambique (RTCM) reflected in Rio Tinto's 2012 year-end accounts. Without admitting to or denying the SEC's allegations related to its books, records and reporting requirements, Rio Tinto will pay a $28M penalty and retain an independent consultant to advise on its current policies, procedures, and controls related to impairment, disclosures and project risk. Former chief executive Tom Albanese has also reached a settlement with the SEC and will pay a $50,000 penalty, without admitting to or denying the allegations related to books and records and internal controls. Rio Tinto said it welcomes closure of the SEC case on appropriate and reasonable terms. With this settlement, all investigations of Rio Tinto regarding this matter have been finalised. Rio Tinto settled claims brought by the Australian Securities and Investment Commission in 2022 and the United Kingdom's Financial Conduct Authority in 2017 relating to the same RTCM impairment. The U.S. Court who approved the SEC settlement previously dismissed a related private putative securities class action in 2019. An appeals court affirmed the dismissal.
|
SONX | Hot Stocks16:31 EST NYSE to commence delisting proceedings against Sonendo - The New York Stock Exchange announced that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Sonendo - ticker symbol SONX - from the NYSE. Trading in the company's common stock will be suspended immediately. NYSE Regulation reached its decision to delist the company's common stock pursuant to Section 802.01B of the NYSE's Listed Company Manual because the company had fallen below the NYSE's continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000. The company has a right to a review of this determination by a committee of the board of directors of the exchange. The NYSE will apply to the Securities and Exchange Commission to delist the common stock upon completion of all applicable procedures, including any appeal by the company of the NYSE Regulation staff's decision.
|
ARCT | Hot Stocks16:26 EST Arcturus Therapeutics treatment of cystic fibrosis granted orphan status - Arcturus Therapeutics' treatment of cystic fibrosis was granted orphan status by the FDA, a post to the agency's website shows. Reference Link
|
NVDA | Hot Stocks16:25 EST Nvidia down about 2% to $491.93 after Q3 report, Q4 guidance - Nvidia shares are down $7.51, or about 2%, to $491.93 in after-hours trading ahead of the company's earnings call.
|
GES | Hot Stocks16:23 EST Guess drops 15% to $20 after slashing FY24 guidance
|
CRDO | Hot Stocks16:15 EST Credo Technology CEO Brennan sells 89,921 ordinary shares - In a regulatory filing, Credo Technology president and CEO William Joseph Brennan disclosed the sale of 89,921 ordinary shares of the company on November 20 at a price of $18.1405 per share.
|
STRO | Hot Stocks16:12 EST Sutro Biopharma promotes Jane Chung to President and COO - Sutro Biopharma announced the promotion of Jane Chung to President and Chief Operating Officer, a newly created role, effective December 1. In this newly created position, Ms. Chung will be responsible for driving operational excellence, strategic growth, and overall business
|
APLS | Hot Stocks16:09 EST Apellis director Dunlop sells 24,000 common shares - In a regulatory filing, Apellis Pharmaceuticals director A. Sinclair Dunlop disclosed the sale of 24,000 common shares of the company on October 17 at a price of $49 per share.
|
JWN | Hot Stocks16:08 EST Nordstrom reports Q3 GMV down 7.1% - Total Company net sales decreased 6.8 percent and GMV decreased 7.1 percent compared with the same period in fiscal 2022. The wind-down of Canadian operations had a negative impact on total Company net sales of 270 basis points. The timing shift of the Anniversary Sale, with roughly one week falling into the third quarter of 2023 versus one day in 2022, had a positive impact on net sales of approximately 200 basis points compared with the third quarter of 2022. For the Nordstrom banner, net sales decreased 9.4 percent and GMV decreased 9.8 percent compared with the same period in fiscal 2022. The wind-down of Canadian operations had a negative impact on Nordstrom banner net sales of 410 basis points. The timing shift of the Anniversary Sale had a positive impact on Nordstrom banner net sales of approximately 300 basis points compared with the third quarter of 2022. For the Nordstrom Rack banner, net sales decreased 1.8 percent compared with the same period in fiscal 2022. Eliminating store fulfillment for Nordstrom Rack digital orders during the third quarter of fiscal 2022 negatively impacted third quarter Rack banner sales by approximately 100 basis points. Digital sales decreased 11.3 percent compared with the same period in fiscal 2022. Eliminating store fulfillment for Nordstrom Rack digital orders during the third quarter of fiscal 2022 negatively impacted third quarter digital sales by approximately 100 basis points. The timing shift of the Anniversary Sale had a positive impact on Company digital sales of approximately 400 basis points compared with the third quarter of 2022. Digital sales represented 34 percent of total sales during the quarter. Gross profit, as a percentage of net sales, of 35.0 percent increased 180 basis points compared with the same period in fiscal 2022 primarily due to lower markdowns, increased inventory productivity and lower buying and occupancy costs, partially offset by deleverage on lower sales. Ending inventory decreased 8.8 percent compared with the same period in fiscal 2022, versus a 6.8 percent decrease in sales.
|
BODY | Hot Stocks16:07 EST Beachbody Company completes reverse stock split - The Beachbody Company announced that the Company's board of directors has approved a reverse stock split of all of its issued and outstanding common stock at a ratio of one post-split share for every fifty pre-split shares, effective November 21,2023. The Company's Class A common stock is expected to begin trading on the split-adjusted basis on the New York Stock Exchange when the stock markets open on November 22, 2023, under the existing trading symbol "BODY," with a new CUSIP number of 073463 309. Mark Goldston, Executive Chairman of BODi, stated, "We are confident that our recently developed turnaround plan will help drive profitability, free cash flow and help to increase our cash on the balance sheet. We have dramatically lowered the breakeven of the company through additional, newly identified reductions in both fixed costs and capital expenditures as part of the ongoing program that began in 2021. As a result of those efforts, we expect to bring the total realized cost savings under the program to a cumulative $165 million by December 31, 2023. In addition to the major cost savings program we have implemented, we are aggressively developing new programs to unlock incremental revenue opportunities. While the execution of our robust turnaround plan will put us on the right path to regain compliance with the NYSE's minimum closing price requirements and drive long-term shareholder value, we believe that instituting a reverse stock split is the most appropriate action at this time to address the uncertainty regarding our listing."
|
SONX | Hot Stocks16:05 EST Sonendo Inc trading halted, news pending
|
MSTR... | Hot Stocks15:50 EST Zhao confirms stepping down as CEO of Binance - Changpeng Zhao, the former CEO of Binance, tweeted: "Today, I stepped down as CEO of Binance. Admittedly, it was not easy to let go emotionally. But I know it is the right thing to do. I made mistakes, and I must take responsibility. This is best for our community, for Binance, and for myself. Binance is no longer a baby. It is time for me to let it walk and run. I know Binance will continue to grow and excel with the deep bench it has. I'm pleased to announce that @_RichardTeng, our now former Global Head of Regional Markets, has been named the new CEO of Binance today... As a shareholder and former CEO with historical knowledge of our company, I will remain available to the team to consult as needed, consistent with the framework set out in our U.S. agency resolutions... On that note, I am proud to point out that in our resolutions with the U.S. agencies they: - do not allege that Binance misappropriated any user funds, and - do not allege that Binance engaged in any market manipulation. Funds are SAFU!" Publicly traded companies in the crypto space include Bit Digital (BTBT), Coinbase (COIN), Core Scientific (CORZ), Greenidge Generation (GREE), Marathon Digital (MARA), MicroStrategy (MSTR), Riot Platforms (RIOT), Stronghold Digital Mining (SDIG) and TeraWulf (WULF). Reference Link
|
MRCY | Hot Stocks15:03 EST Mercury Systems shareholder Jana buys $8.7M in company shares - Shareholder of Mercury Systems JANA Partners disclosed the purchase of 259,922 shares of company stock at $33.42 per share between November 16 and November 20 for a total transaction amount of $8,685,710.
|
NIO... | Hot Stocks14:57 EST China's Nio, Changan Auto team on development of battery swapping platform - On November 21 Changan Automobile and NIO signed the partnership agreement on battery swapping in Chongqing. The two parties will jointly facilitate the formulation of standards for swappable batteries, build and share the battery swapping network, develop swappable vehicles, and establish an efficient battery asset management mechanism....Huarong ZHU, Chairman and Party Secretary of Changan Automobile, and William LI, Founder, Chairman, and CEO of NIO held a dialogue and witnessed the signing of the agreement. The signing ceremony was also attended by Jun WANG, President of Changan Automobile, Hui WANG, Vice President of Changan Automobile, Chenghao DENG, General Manager of Deepal Automobile, Lihong QIN, Co-Founder and President of NIO, and Fei SHEN, Senior Vice President of NIO. NIO is a leading smart electric vehicle company, and the world's largest operator of battery swapping network for smart electric vehicles. So far, it has over 2,100 Power Swap Stations up and running worldwide. In 2023, NIO plans to install 1,000 new stations in China. As of November 20, NIO had provided over 32M battery swaps for users. ...As a leading automotive company in China, Changan Automobile has demonstrated great determination and strong execution in electrification and transformation. With this partnership, NIO and Changan Automobile will jointly contribute to the development and transformation of the industry.""As China is doubling down on new energy and smart connected vehicles, the implementation of NIO's battery swapping model marks a significant milestone for the industry," said Huarong ZHU, Chairman of Changan Automobile.Other Publicly traded companies in the space may include: BYD (BYD) Li Auto(LI) XPeng (XPEV) and Tesla (TSLA). Reference Link
|
EADSY | Hot Stocks14:40 EST SMBC Aviation Capital orders 60 Airbus A320neo aircrafts - "Leading aircraft lessor SMBC Aviation Capital has ordered a further 60 A320neo Family aircraft taking its total for the type to nearly 340 aircraft purchased directly from Airbus. Together with its existing orders for the A320neo Family, this new one ensures SMBC Aviation Capital will have a continuous delivery stream to beyond the end of the decade, deepening Airbus and SMBC Aviation Capital's long standing strategic partnership on the A320neo Family programme. This transaction is further testament of sustained global demand for technologically advanced, fuel-efficient aircraft, and comes amidst the continuing strong recovery in air travel worldwide," said Peter Barrett, CEO of SMBC Aviation Capital. "With sustainability and operational efficiency remaining key priorities for our customers, we anticipate even greater demand for aircraft such as the A320neo and the A321neo in the years ahead. We look forward to strengthening our valued partnership with Airbus as we help our customers navigate these priorities." said the company in an earlier statement.
|
CANF | Hot Stocks14:15 EST Can-Fite BioPharma trading resumes
|
SOFI | Hot Stocks13:52 EST SoFi Technologies CEO buys 22,500 shares - SoFi Technologies CEO Anthony Noto purchased 22,500 shares of the company's common stock in multiple trades on November 21 with an average purchase price of $6.5017, according to a regulatory filing. Reference Link
|
CANF | Hot Stocks13:33 EST Can-Fite BioPharma trading halted, news pending
|
UBER BIG | Hot Stocks13:06 EST Uber enters nationwide partnership with Big Lots - Uber Technologies (UBER) announced a new nationwide partnership with Big Lots (BIG), bringing the home discount retailer's massive selection to the Uber Eats app. Just in time for the busiest shopping season of the year more than 1,200 Big Lots retail locations across the US are now available for consumers to shop with Uber Eats.
|
KNSW | Hot Stocks12:20 EST Knightswan Acquisition Corp trading resumes
|
WMT | Hot Stocks12:14 EST Walmart introduces parcel stations to speed up delivery - Jennifer McKeehan, Senior Vice President, Transportation and Delivery, Walmart U.S., said in corporate news post: "With 4,700 stores located within 10 miles of 90% of the U.S. population, we have a unique ability to serve customers quickly. It's why our stores have evolved to be more than just a place to shop - they're now online fulfillment centers and delivery hubs, supported by an extensive transportation and last-mile delivery network. Today we have over 4,000 stores operating as delivery hubs, fulfilling and delivering a variety of different order types. As we continue growing our omnichannel fulfillment capabilities, I'm excited to share what's next: adding parcel stations to our hubs. Parcel stations help us move goods even faster to a customer's home by using our Private Fleet to transport more online orders. Packages originate in our fulfillment centers and move to a sortation center or directly to stores, where they are then delivered to a customer's home using our last-mile delivery network. In many ways you can think of a parcel station like a mini post office that receives and delivers packages... We will have over 40 parcel stations in stores by the end of the year, with many operating now in time for the busy holiday shopping season. We plan to expand this capability to other locations next year as we better serve customers with speed, accuracy and reliability. As we do, we'll not only enhance the way we serve Walmart customers but also other businesses with Walmart GoLocal." Reference Link
|
OTGLY... | Hot Stocks12:11 EST CD Projekt says 'Cyberpunk 2077: Ultimate Edition' out December 5 - CD Projekt (OTGLY) said that, on December 5, it will release "Cyberpunk 2077: Ultimate Edition" for PC, Xbox Series X/S (MSFT), and PlayStation 5 (SONY). The new edition combines the most up-to-date version of 2020's "Cyberpunk 2077" as well its its "Phantom Liberty" expansion. The title will be available digitally and physically in select markets starting December 5. Reference Link
|
KNSW | Hot Stocks12:07 EST KnightSwan Acquisition won't consummate an initial business combination - KnightSwan Acquisition Corporation, a publicly-traded special purpose acquisition company, announced that its board of directors has determined to redeem all of its outstanding shares of Class A common stock, par value $0.0001 per share because the company will not consummate an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation. The previously disclosed non-binding letter of intent has been terminated in accordance with its terms. As stated in the Certificate of Incorporation, if the company is unable to complete an initial business combination by July 25, 2024, the company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter subject to lawfully available funds therefor, redeem 100% of the public shares in consideration of a per share price, payable in cash.
|
FE | Hot Stocks12:05 EST FirstEnergy appoints Toby Thomas as COO - FirstEnergy announced that Wade Smith has been named president, FirstEnergy Utilities, and Toby Thomas has been named COO of FirstEnergy, effective Dec. 18 and Nov. 30, respectively. The addition of these two senior executives is an important step in driving forward the company's transformation into a premier electric utility. Both leaders will report directly to President and CEO Brian Tierney. Today's executive appointments are the first in a series of senior roles FirstEnergy will fill as part of a new business structure that will enhance execution at the utility level by shifting decision making and accountability closer to customers. As president, FirstEnergy Utilities, Smith will oversee the company's state businesses - Ohio, Pennsylvania, New Jersey and a combined West Virginia/Maryland division - as well as its stand-alone transmission companies. The leaders of these five businesses will report to Smith and be responsible for financial and operational performance as well as regulatory outcomes in their respective areas. The company is engaging with internal and external candidates to fill these leadership positions. Smith will also have responsibility for FirstEnergy's Rates & Regulatory Affairs and External Affairs groups. As COO, Thomas will be responsible for a broad range of transmission and distribution business functions including planning and protection, transmission and substation engineering, project and construction management, system operations, support operations and safety and human performance. In addition, the Customer Experience group will report to Thomas. Smith most recently served as COO of Puget Sound Energy. Thomas joins FirstEnergy after more than two decades at American Electric Power, where he most recently served as senior vice president - AEP Energy Delivery.
|
AIM | Hot Stocks12:03 EST AIM ImmunoTech completes treatment of last subject in Phase 2 study of Ampligen - AIM ImmunoTech announced the last subject has completed treatment in the Company's Phase 2 study evaluating Ampligen as a potential therapeutic for people with the Post-COVID condition of fatigue. As previously announced, the Company completed enrollment in the AMP-518 study in August 2023. Approximately 80 subjects, ages 18 to 60 years, were enrolled and randomized 1:1 to receive twice-weekly intravenous infusions of Ampligen or placebo for 12 weeks, with a follow-up phase of two weeks. To date, no severe adverse events have been reported. The Company remains on track to report topline data as early as Q1 2024. The AMP-518 clinical trial is a two-arm, randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy and safety of Ampligen in subjects experiencing the post-COVID condition of fatigue. The primary protocol planned outcome measure of the study is change from baseline to week 13 in PROMIS Fatigue Score. Other protocol planned study outcomes include: change from baseline to week 6 in PROMIS Fatigue Score; change from baseline to weeks 6 and 13 in distance traveled during a Six-Minute Walk Test; proportion of subjects that surpass 54 meters in the Six-Minute Walk Test at the end of 12-week treatment phase; change from baseline to weeks 6 and 13 in PROMIS Cognitive Function Score; and change from baseline to weeks 6 and 13 in PROMIS Sleep Disturbance Score.
|
FINV | Hot Stocks12:00 EST FinVolution falls -11.6% - FinVolution is down -11.6%, or -59c to $4.54.
|
AEO | Hot Stocks12:00 EST American Eagle falls -15.8% - American Eagle is down -15.8%, or -$3.13 to $16.62.
|
SBSW | Hot Stocks12:00 EST Sibanye Stillwater falls -18.6% - Sibanye Stillwater is down -18.6%, or -96c to $4.24.
|
DY | Hot Stocks12:00 EST Dycom rises 16.8% - Dycom is up 16.8%, or $14.53 to $101.18.
|
AORT | Hot Stocks12:00 EST Artivion rises 17.1% - Artivion is up 17.1%, or $2.41 to $16.53.
|
BURL | Hot Stocks12:00 EST Burlington Stores rises 21.8% - Burlington Stores is up 21.8%, or $29.75 to $166.47.
|
EBAY BX | Hot Stocks11:51 EST eBay announces support for offer led by Permira, Blackstone to acquire Adevinta - eBay (EBAY) announced its support for the voluntary tender offer led by Permira and Blackstone (BX) to acquire all the publicly traded shares of Adevinta. As part of the transaction, eBay would sell 50% of its shares for an estimated $2.2B and would exchange the remaining shares for an equity stake of approximately 20% in the newly privatized company. "We strongly support this offer, which we firmly believe is in the best interests of our shareholders. We would sell half our stake for approximately $2.2B in cash at a premium of more than 50% to the undisturbed price of Adevinta shares. We would recognize immediate value in the short-term, while continuing to maintain a financial interest in Adevinta alongside Schibsted and other world-class investors," said Jamie Iannone, Chief Executive Officer at eBay. The offer is subject to the satisfaction or waiver of certain regulatory approvals and a minimum offer acceptance level of more than 90% of the issued and outstanding share capital and voting rights of Adevinta as well as other customary closing conditions. The offer is expected to be completed in the second quarter of 2024, subject to satisfaction of the conditions of the offer.
|
AEO | Hot Stocks11:35 EST American Eagle seeing sustained momentum across brands, QTD revenue up MSD
|
$BTC... | Hot Stocks11:17 EST SEC charges Kraken for operating as unregistered securities exchange - In a Monday press release, The Securities and Exchange Commission announced it charged Payward Inc. and Payward Ventures Inc., together known as Kraken, with operating Kraken's crypto trading platform as an unregistered securities exchange, broker, dealer, and clearing agency. According to the SEC's complaint, since at least September 2018, Kraken has made hundreds of millions of dollars unlawfully facilitating the buying and selling of crypto asset securities. The SEC alleges that Kraken intertwines the traditional services of an exchange, broker, dealer, and clearing agency without having registered any of those functions with the Commission as required by law. Kraken's alleged failure to register these functions has deprived investors of significant protections, including inspection by the SEC, recordkeeping requirements, and safeguards against conflicts of interest, among others. Through its platform's services, Kraken allegedly: Provides a marketplace that brings together the orders for securities of multiple buyers and sellers using established, non-discretionary methods under which such orders interact, and thus operates as an exchange; Engages in the business of effecting securities transactions for the accounts of Kraken customers, and thus operates as a broker; Engages in the business of buying and selling securities for its own account without an applicable exception, and thus operates as a dealer; and serves as an intermediary in settling transactions in crypto asset securities by Kraken customers, and acts as a securities depository, and thus operates as a clearing agency. The SEC's complaint, filed in federal district court in San Francisco, alleges that Kraken violated the registration provisions of the Securities Exchange Act of 1934 and seeks injunctive relief, conduct-based injunctions, disgorgement of ill-gotten gains plus interest, and penalties. Reference Link
|
MSFT | Hot Stocks11:00 EST Microsoft CTO tells OpenAI staff they have role at Microsoft - Microsoft CTO Kevin Scott said via X: "To my partners at OpenAI: We have seen your petition and appreciate your desire potentially to join Sam Altman at Microsoft's new AI Research Lab. Know that if needed, you have a role at Microsoft that matches your compensation and advances our collective mission."
|
AMZN | Hot Stocks10:40 EST Amazon weakness attributed to Bezos stock sale speculation - Shares of Amazon are down $4.17, or nearly 3%, to $141.96 in Tuesday morning trading. A regulatory filing made last week showed that Amazon founder and executive chair Jeff Bezos gifted 1,673,916 shares on November 15 as contributions to non-profit organizations and today's weakness has been attributed to speculation of stock sales by the billionaire. Bezos owns 988,251,817 shares of Amazon common stock, according to the filing dated November 17 with the SEC, and CNBC's David Faber said on-air earlier, citing market speculation among traders, that Bezos may be selling 8M-10M of those shares, or potentially $1B worth of stock. "He's got a lot of things going on. A lot of stuff to fund," Faber said while speaking on-air about the speculation. Reference Link
|
WWW | Hot Stocks10:38 EST Wolverine Boots and Apparel licenses sock business to Renfro Brands - Wolverine Boots and Apparel announced that it has made the strategic decision to license their sock business exclusively to Renfro Brands. "To better service the needs of our retailer partners and consumers, the decision to partner with Renfro reinforces our prioritization of the sock category," said Tom Kennedy, President of Wolverine Boots and Wolverine Worldwide's Work Group. "Wolverine, in partnership with Renfro, is focused on providing the highest quality products in the industry in order to elevate our commitment to comfort and durability." Wolverine socks produced by Renfro will be in market in January 2024 and will be available at retailers nationwide as well as Wolverine.com.
|
EPOW | Hot Stocks10:35 EST Sunrise New Energy to construct carbon nanotube conductive additive plant - Sunrise New Energy announced its intention to construct a carbon nanotube plant in the United States by 2024, with an annual production capacity of 720 metric tons. The project envisions a main facility spanning 35,000 square meters and over a hundred production and testing equipment units. After reaching full production capacity, it is estimated that the project will generate approximately $70 million in annual revenue. Building a carbon nanotube production facility in the United States is expected to result in significant cost savings in transportation and enhance the Company's profitability. Carbon nanotubes, characterized by their low density and difficulty of dispersion, are typically prepared as dispersed slurries by manufacturers, with a solid content of around 5% and a majority of the slurry consisting of solvents. During large-scale transportation, particularly across borders, transportation costs can become substantial. Therefore, establishing local production facilities reduces transportation distances and associated costs. Carbon nanotube, a novel conductive additive, play a crucial role as one of the key auxiliary materials in lithium-ion batteries. When mixed with cathode and anode materials, carbon nanotubes improve the conductivity of the electrode sheets. These additives facilitate the formation of a reliable conductive network, filling the gaps between active materials in the electrode. Overall, conductive additives account for approximately 5% of the total cost of lithium-ion batteries. Compared to traditional conductive additives, such as carbon black, carbon nanotubes represent a new generation of materials that form a more comprehensive network of linear contacts between active materials. This characteristic significantly enhances conductivity and reduces the required additive amount. Typically, carbon black additives constitute around 3% of the cathode material, while the addition of carbon nanotubes can be reduced to 0.5%-1.0%. Sunrise New Energy believes that establishing a carbon nanotube plant in the United States will further strengthen its position as a leading EV battery material manufacturer. Details of the construction plan will be disclosed following approval by the board of directors. Furthermore, the Company anticipates releasing its financial report for the first half of 2023 in December, within the prescribed legal and regulatory deadlines.
|
F | Hot Stocks10:34 EST Ford moving ahead with 'right-sized' BlueOval Battery Park project in Marshall - Ford stated in an update posted to its corporate newsroom: "While we remain bullish on our long-term strategy for electric vehicles, we are re-timing and resizing some investments. As stated previously, we have been evaluating BlueOval Battery Park Michigan in Marshall. We are pleased to confirm we are moving ahead with the Marshall project, consistent with the Ford+ plan for growth and value creation. However, we are right-sizing as we balance investment, growth, and profitability. The facility will now create more than 1,700 good-paying American jobs to produce a planned capacity of approximately 20 GWh. We still expect BlueOval Battery Park Michigan to be the first of Ford's battery plants of this kind when it begins producing LFP battery cells starting in 2026." Reference Link
|
UPH | Hot Stocks10:31 EST UpHealth resumes trading on New York Stock Exchange - UpHealth announced that the company has resumed trading on the New York Stock Exchange under the symbol "UPH." Trading of UPH resumed, today on November 21, at market open following the disclosures provided in the November 20 filings, accessible via the company's Investor Relations website and the Securities and Exchange Commission, the company stated.
|
ADI | Hot Stocks10:27 EST Analog Devices has 'pretty strong confidence' that Automotive will grow in 2024
|
ADI | Hot Stocks10:26 EST Analog Devices saw cancellations fall, bookings stabilize during Q4 - The company said this gives them confidence that the ongoing inventory correction will taper through the first half of the fiscal year. Comments taken from Q4 earnings conference call.
|
MIRA | Hot Stocks10:14 EST Mira Pharmaceuticals announces insights from presentation on MIRA1a - MIRA Pharmaceuticals revealed insights into the cognitively enhancing effects of MIRA1a in normal mice during a presentation at the University of Louisville's Christine Lee Brown Envirome Institute's Grand Rounds from Dr. Adam Kaplin, MD, Ph.D., President and Chief Scientific Officer of MIRA Pharmaceuticals and Adjunct Faculty member at the Johns Hopkins School of Medicine. Dr. Kaplin's presentation covered his research on psychotropic drug development, specifically examining the contrasting properties of THC and MIRA1a, a novel, cutting-edge THC analog. Key Findings from Dr. Kaplin's Presentation: Overcoming Biphasic Response: While THC exhibited limitations with a biphasic response, being therapeutic at low doses but toxic at high doses, MIRA1a showcased unparalleled stability, even at high doses, without any toxic side effects. Unprecedented Cognitive Boost: MIRA1a demonstrated a doubling of the performance of normal adult mice in learning and memory tests, showcasing MIRA1a's potential to elevate cognitive abilities beyond normal thresholds.
|
LQR | Hot Stocks10:12 EST LQR House board approves 60-for-1 reverse stock split - LQR House announces that both the Board of Directors have approved an up to 60-for-1 reverse stock split of the Company's common stock. The reverse split is pending approval from NASDAQ, and upon receiving approval, the Company will issue a news release announcing the effective date. The split will also apply to Company common stock issuable upon the exercise of the Company's outstanding stock options and warrants. No fractional shares will be issued; instead, any fractional entitlements will be rounded down to the next highest whole number.
|
BGNE | Hot Stocks10:07 EST BeiGene treatment of multiple myeloma granted orphan designation - BeiGene's Sonrotoclax was granted FDA orphan designation as a treatment of multiple myeloma, according to a post to the agency's website. Reference Link
|
AZN | Hot Stocks10:07 EST AstraZeneca's Alexion granted orphan status for glioma treament - The FDA granted AstraZeneca's Alexion Pharmaceuticals orphan status for selumetinib, its treatment of malignant glioma. Reference Link
|
RIO | Hot Stocks10:05 EST Rio Tinto, Aymium partner to trial renewable biocarbon product - Rio Tinto and Aymium have partnered to develop and trial a renewable biocarbon product for use as an alternative resource to reduce emissions in large scale industrial processes. The product has been successfully trialled as a replacement for anthracite used in ilmenite smelting processes at Rio Tinto's metallurgical complex in Sorel-Tracy, a world leading producer of high-grade titanium dioxide feedstock as well as iron and steel for specialised applications. In a strengthening of the partnership, Rio Tinto has made a further equity investment in Aymium following its participation in a funding round in 2022. The second investment is part of Rio Tinto's support for innovations needed to meet its 2030 emission reduction targets and deliver lower carbon supply chains. The partners will now be working together on options for large-scale production of a biocarbon product. Funds from this investment will be directed towards advancing the construction of Aymium's new production facilities in North America and supporting their Research and Development initiatives.
|
TBTC | Hot Stocks10:03 EST Table Trac to install CasinoTrac system at Oklahoma resort - Table Trac announces it has signed an agreement with the Apache Tribe of Oklahoma, to install its CasinoTrac casino management system at Oklahoma's newest full-service gaming destination, the Apache Lonestar Casino, in Devol, OK.
|
HII | Hot Stocks10:02 EST Huntington Ingalls secures Air Force contract to enhance information-sharing - HII announced that its Mission Technologies division was awarded a three-year task order under the Analytical and Technical Services contract to provide information-sharing capabilities to the Five Eyes intelligence alliance comprised of the United States, Australia, Canada, New Zealand and the United Kingdom. The objective of the Pegasus task order, administered by the Secretary of the Air Force's Concept, Development and Management Mission Partner Capability Office, is to provide email, phone, video and chat capabilities to enable seamless collaboration between Five Eyes warfighters at both a national and international level.
|
MS | Hot Stocks10:01 EST Morgan Stanley Infrastructure Partnres announces investment in UltraEdge - Morgan Stanley Investment Management, through investment funds managed by Morgan Stanley Infrastructure Partners, a private infrastructure investment platform within MSIM, announced it has entered into an exclusivity agreement to partner with Altice France S.A. to establish the first nationwide independent distributed colocation provider in France through the acquisition of a majority interest in UltraEdge, subject to regulatory approvals and other customary conditions. "We believe the opportunity to create an independent and distributed edge colocation provider, benefiting from access to SFR's nationwide fiber infrastructure in France, makes UltraEdge a very attractive investment for MSIP," said Yacine Saidji, Managing Director and Co-Head of Europe for MSIP. MSIP will partner with Altice France to continue upgrading the infrastructure and increasing the density of the portfolio.
|
FINV | Hot Stocks10:00 EST FinVolution falls -14.1% - FinVolution is down -14.1%, or -72c to $4.42.
|
AEO | Hot Stocks10:00 EST American Eagle falls -17.7% - American Eagle is down -17.7%, or -$3.49 to $16.26.
|
SBSW | Hot Stocks10:00 EST Sibanye Stillwater falls -20.4% - Sibanye Stillwater is down -20.4%, or -$1.06 to $4.14.
|
AORT | Hot Stocks10:00 EST Artivion rises 11.4% - Artivion is up 11.4%, or $1.61 to $15.73.
|
DY | Hot Stocks10:00 EST Dycom rises 13.8% - Dycom is up 13.8%, or $11.95 to $98.60.
|
LOW | Hot Stocks10:00 EST Lowe's says cost environment leveled off 'dramatically' through the year - Says investing in price "strategically" with an eye towards holding margins. Says "continues to be pleased" with Pro customer sales. Expects 'modest' share buybacks in Q4. Says capital allocation strategy "remains unchanged."
|
BURL | Hot Stocks10:00 EST Burlington Stores rises 17.2% - Burlington Stores is up 17.2%, or $23.54 to $160.25.
|
ATGL | Hot Stocks09:56 EST Alpha Technology Group Ltd trading resumes
|
TMBR | Hot Stocks09:55 EST Timber Pharmaceuticals Inc trading resumes
|
ATGL | Hot Stocks09:51 EST Alpha Technology Group Ltd trading halted, volatility trading pause
|
IMMX | Hot Stocks09:49 EST Immix Biopharma announces FDA approval of IND application for NXC-201 - Immix Biopharma announced that the U.S. Food and Drug Administration has cleared the Investigational New Drug application for BCMA CAR-T NXC-201. With this clearance, NEXICART-2 is to expand studies of NXC-201 in relapsed/refractory AL Amyloidosis to the United States. Favorable tolerability enables potential expansion into autoimmune indications. 72 patients have been dosed with NXC-201 ex-U.S. Relapsed/refractory AL Amyloidosis dose escalation levels included: 150 x 106, 450 x 106, and 800 x 106 CAR+T cells, demonstrating a 100% overall response rate. Relapsed/refractory multiple myeloma dose escalation levels included: 150 x 106, 450 x 106, and 800 x 106 CAR+T cells, demonstrating a 95% overall response rate with median 11.9 months of follow-up. NXC-201 publications, presentations and posters include the 65th American Society of Hematology Annual Meeting & Exposition, 27th Annual American Society for Gene and Cell Therapy, 20th International Myeloma Society Annual Meeting, Clinical Cancer Research, 49th Annual Meeting of the European Society for Blood and Marrow Transplantation and Haematologica.
|
PLTR ACN | Hot Stocks09:47 EST Palantir group wins National Health Service software contract award - The United Kingdom National Health Service said it will roll out new software from spring next year "to deliver better joined-up care for millions of patients, help tackle waiting lists and reduce hospital discharge delays." Following an open and competitive tender process, the contract to provide the software has been awarded to a group led by Palantir Technologies UK (PLTR), with support from Accenture (ACN), PwC, NECS and Carnall Farrar, the agency said in a statement. The contract award will see investment over the course of seven years as more trusts join the platform. In the first contract year, investment is expected to be at least GBP 25.6M. Over the contractual period of seven years, there will be up to GBP 330M investment in the Federated Data Platform and associated services. Reference Link
|
FINV | Hot Stocks09:47 EST FinVolution falls -12.1% - FinVolution is down -12.1%, or -62c to $4.52.
|
AEO | Hot Stocks09:47 EST American Eagle falls -15.6% - American Eagle is down -15.6%, or -$3.08 to $16.67.
|
SBSW | Hot Stocks09:47 EST Sibanye Stillwater falls -21.2% - Sibanye Stillwater is down -21.2%, or -$1.10 to $4.10.
|
DY | Hot Stocks09:47 EST Dycom rises 14.9% - Dycom is up 14.9%, or $12.89 to $99.55.
|
AORT | Hot Stocks09:47 EST Artivion rises 15.4% - Artivion is up 15.4%, or $2.18 to $16.30.
|
BURL | Hot Stocks09:47 EST Burlington Stores rises 17.5% - Burlington Stores is up 17.5%, or $23.91 to $160.62.
|
MCAF | Hot Stocks09:39 EST Mountain Crest Acquisition Corp IV trading resumes
|
TMBR | Hot Stocks09:36 EST Timber Pharmaceuticals Inc trading halted, news pending
|
MCAF | Hot Stocks09:34 EST Mountain Crest Acquisition Corp IV trading halted, volatility trading pause
|
GEHC | Hot Stocks09:33 EST GE HealthCare announces new version of Digital Expert Access, deal with IONIC - GE HealthCare announced that it has received U.S. FDA 510(k) Clearance for the new version of Digital Expert Access with remote scanning, the first remote patient scan solution with 510(k) Clearance. "Digital Expert Access enables the sharing of expertise, best practices, and in-the-moment advice, as well as real-time, remote console control," the company said in a statement. Additionally, GE HealthCare has entered into an exclusive distribution agreement with IONIC Health, an independent Brazilian-born global technology company.
|
SGBX | Hot Stocks09:32 EST Safe & Green signs non-binding LOI for real estate AI software integration - Safe and Green Development Corporation signed a non-binding Letter of Intent with Majestic World Holdings relating to a proposed strategic partnership between SG Devco and MWH, wherein SG Devco will invest in MWH in exchange for access to MWH's software platform Xene. The XENE Platform, powered by advanced AI technology, has the goal of creating a decentralized real estate marketplace, creating an all-in-one solution that brings banks, institutions, home builders, clients, agents, vendors, gig workers, and insurers into a seamlessly integrated and structured AI-driven environment. This development expects to significantly save time and resources for all parties involved. The platform streamlines property transactions, offering a cost-effective alternative to traditional buyers' agent models. Agents joining the platform can enjoy numerous benefits, including retaining their license, branding, and signs while benefiting from Xene's Arizona referral fee agreement and a simplified monthly membership structure. Additional details about the proposed project will be communicated when the Company achieves relevant milestones.
|
LOW | Hot Stocks09:29 EST Lowe's sees Q4 SSS 'consistent' with Q3
|
VLCN | Hot Stocks09:29 EST Volcon appoints Doug Cline as director of sales for the U.S. - Volcon announces the appointment of Doug Cline as the new Director of Sales for the United States. As the former Director of OEM Partnerships at Dominion DMS, Doug played a pivotal role in negotiating and closing strategic partnerships with industry-leading SaaS companies.
|
LOW | Hot Stocks09:29 EST Lowe's says expanding private brand portfolio - Says rural store initiative gaining traction, may look to expand. Says shrink in-line with prior year.
|
AVTA | Hot Stocks09:17 EST Avantax welcomes Lincoln Sparrow Advisors team to Avantax Community - Avantax welcomes Joshua B. Heims, AIF, and Alan Gnoinski and their Lincoln Sparrow Advisors team to the Avantax Community. The financial advisors have approximately $100 million in total client assets as of September 2023.
|
MBOT | Hot Stocks09:16 EST Microbot Medical appoints Juan Diaz-Cartelle as CMO - Microbot Medical announced the appointment of Dr. Juan Diaz-Cartelle as its new Chief Medical Officer, effective December 1, 2023. The hiring of Dr. Diaz-Cartelle, a U.S.-based physician, coincides with the transition of the Company focusing mainly on research and development in Israel to the Company increasing its U.S.-based activities, which includes its planned clinical trials for the LIBERTY Endovascular Robotic Surgical System in the U.S., the regulatory process with the FDA and establishing the commercial foundations to enter the U.S market. of experience in the endovascular and interventional space, along with an impressive track record in clinical research. Before joining the Company, Dr. Diaz-Cartelle served for 14 years as the Senior Medical Director for the Peripheral Interventional Division at Boston Scientific Corporation. Dr. Diaz-Cartelle succeeds Dr. Eyal Morag, the Company's previous CMO.
|
SPHR MSGE | Hot Stocks09:15 EST Sphere Entertainment no longer plans to develop a Sphere in United Kingdom - In a regulatory filing, Sphere Entertainment reported that on November 21, the company announced that it was formally notified by the Mayor of London that its planning application for a Sphere venue in Stratford, London was not approved. "In light of this decision, the company no longer plans to allocate resources towards the development of a Sphere in the United Kingdom. The company continues to have substantive discussions regarding the development of Sphere in other international markets. In connection with this decision, the company expects to record a non-cash impairment charge for project costs, primarily related to professional fees, of approximately $80M in the quarter ending December 31, 2023. The company does not expect any significant estimated future cash expenditures associated with the impairment charge. In addition, the company is evaluating its options regarding the disposition of approximately $77M of real estate acquired in connection with this project and may incur an additional non-cash impairment charge associated with such capitalized real estate," the filing stated.
|
RGF | Hot Stocks09:14 EST Real Good Food announces debt refinancing agreement - The Real Good Food Company announced the signing of a definitive debt refinancing agreement with PMC Financial Services Group, which is expected to enhance the Company's liquidity position by up to $15 million. Per the terms of the agreement, the Company entered into a new $45.0 million second lien loan agreement with PMC. This new loan will pay down $20 million of existing term loans and a portion of the Company's existing revolving credit facility. After closing, capacity under the revolving credit facility will be $70 million, giving the Company access to an incremental $15 million in liquidity. This new second lien loan will mature December 31, 2025 carrying a 9% payment-in-kind interest and 9% cash interest. PMC will be issued penny warrants for a 5% equity interest in the Company, which are exercisable between December 31, 2025 and November 20, 2033. In addition, terms for the Company's equipment loan were amended to be interest only until May 31, 2024.
|
SGN | Hot Stocks09:14 EST Signing Day Sports to investigate stock price decline - Signing Day Sports stated that it is not aware of any fundamental business reason for the precipitous decline in its stock since the commencement of trading on the NYSE American exchange, and the company believes that such decline may be the result of illegal short selling in its stock. The company has commenced an investigation into the trading of its stock and will take appropriate legal action based on its findings.
|
ATIF | Hot Stocks09:12 EST ATIF Holdings awarded new $800K listing advisory contract - ATIF Holdings subsidiary ATIF Business Management has entered into a listing advisory services agreement with a U.S. based electronic technology innovation products company for an amount of US $800K. Under the terms of the agreement, the company will provide the client with IPO advisory services and lead the client's IPO process through the company's team and the engagement of third parties for audit, valuation, stock exchange advisory, investor relations and other IPO services.
|
LOW | Hot Stocks09:11 EST Lowe's says customers prioritizing experiences over goods - Saw increased pressure on bigger ticket purchases in Q3. Expects to grow Pro sales at 2x the pace of the market. "Pleased" with performance of outlet locations. Says rural customers best DIY segment. Says "bullish" on medium to long term outlook of housing industry. Comments taken from Q3 earnings conference call.
|
SYRA | Hot Stocks09:11 EST Syra Health awarded five-year $275K contract by City of San Antonio - Syra Health has been awarded a five-year contract worth $275K by the City of San Antonio to evaluate its Racial and Ethnic Approaches to Community Health - REACH - Healthy Neighborhoods Project. The purpose of the U.S. Department of Health and Human Services REACH Project is to expand the existing Healthy Neighborhoods program to promote food and nutrition security, safe and accessible physical activity, standards in Early Care and Education settings, and adult vaccines among African American and Latino communities on the near East, South, and West sides of San Antonio, Texas.
|
PCT | Hot Stocks09:10 EST PureCycle releases life cycle assessment results for European facility - PureCycle Technologies released new data from a third-party baseline Life Cycle Assessment study that shows the future polypropylene waste purification plant at the port of Antwerp in Belgium is expected to release fewer carbon emissions, use less energy and rely upon less fossil resources than global virgin plastic production. The study was conducted by the well-known independent assurance and risk management expert, DNV, following the ISO-14040/44 LCA-framework. Based on the estimates from PureCycle's flagship facility in Ironton, Ohio and the energy grid in Belgium, the study found that the port of Antwerp facility will consume 86% less energy than global virgin PP production. Assessment data also indicates that the European facility is expected to reduce green-house gas emissions by 61% and reduce fossil-based resource usage by 64% when compared to virgin plastic. In 2022, a third party LCA study conducted by Boundless for PureCycle's Ironton, Ohio plant projected the site would use 79% less energy andhave 35% lower carbon emissions than new PP plastic. The study also indicated that future PureCycle plants could further improve on these initial estimates and appears to have been confirmed by the DNV study.
|
COUP | Hot Stocks09:09 EST Coupa Software appoints Kevin Burns as CFO - Coupa has named Kevin Burns as CFO. Most recently, Burns served as CFO at global technology company Dynatrace, where he led its IPO in 2019. Prior to that, he was the CFO and COO of iCAD and AMICAS, which was acquired by Merge Healthcare.
|
HUT | Hot Stocks09:09 EST US Bitcoin stockholders approve Hut 8 Mining transaction - U.S. Data Mining Group, Inc. d/b/a US Bitcoin Corp USBTC is thrilled to announce that its stockholders have overwhelmingly voted in favor of the proposed business combination with Hut 8 Mining or Hut 8 one of North America's largest and innovative digital asset mining pioneers. This decision follows the recent approval by Hut 8's shareholders as announced on Sept. 13..."I'm incredibly proud of what we've accomplished at US Bitcoin Corp. and equally excited about our future with Hut 8," says Asher Genoot, President of US Bitcoin Corp. "Our shareholders have seen the immense value and potential in this merger of equals, and their overwhelming support is testament to this. ..the common stock of the combined company, Hut 8 is expected to be listed on Nasdaq and the Toronto Stock Exchange under the proposed ticker symbol "HUT".
|
LTHCF | Hot Stocks09:09 EST Lithium Ionic advances environmental, social permitting process - Lithium Ionic reports a major milestone with the application of a Concomitant Environmental and Installation License submitted to the State of Minas Gerais for the construction and development of its Bandeira lithium Project. The Preliminary Economic Assessment, PEA, for Bandeira announced last month defined an underground mining operation which provides a reduced environmental footprint relative to other development options. This development approach qualifies the Bandeira project as a candidate for the accelerated LAC license that would result in the environmental and social license, together with an authorization to begin construction. As part of the application, the Company submitted both an RCA and PCA which have been underway since March 2023 by local environmental consultancy group, NEO Agroambiental Ltda., with assistance from Lithium Ionic's technical team. Blake Hylands, P.Geo., CEO of Lithium Ionic, commented, "The submission of the LAC permit application marks a major milestone on our development path towards becoming a near-term producer of high-quality lithium concentrate. We are pleased that Minas Gerais state officials recognize the importance of supporting the development of the battery materials sector in the region and we are confident that having our project on their priority business development list will result in our application being evaluated accordingly, without delay."
|
WRAP | Hot Stocks09:07 EST Wrap Technologies announces expanding deployments of BolaWrap 150 - Wrap Technologies announces the expanding deployments of its innovative BolaWrap 150 Remote Restraint device in the field. This expansion heralds a transformative era in law enforcement, emphasizing BolaWrap's exceptional capacity in providing a safer and non-harmful approach in a wide array of situations that officers encounter, including those involving mental health crises, homelessness, and substance abuse. "Our mission has always been to equip law enforcement with tools that promote both officer safety and community welfare," said Kevin Mullins, CEO of Wrap Technologies. "We are seeing increased use of BolaWrap in the field as reported by law enforcement agencies. The growing adoption of BolaWrap highlights the importance of a non-lethal approach in modern policing. We are thrilled to see our technology playing a pivotal role in transforming how officers address challenging situations."
|
SCLX | Hot Stocks09:06 EST Scilex announces production increase , availability of ELYXYB - Scilex announced the increase of ELYXYB manufacturing to meet its rising demand for ELYXYB and increased stocking needs in its distribution center. Scilex has met another significant corporate objective and produced our first commercial batch with Scilex labeled ELYXYB which will enable the Company to meet the growing demands of future customers seeking a rapid onset pain management regimen for the acute treatment of migraine. The company believes ELYXYB is the first and only ready to use oral solution designed to deliver fast and long-lasting migraine relief with the proven safety of COX-2 selectivity that is FDA-approved for the acute treatment of migraine, with or without aura, in adults. ELYXYB was studied in two randomized, double-blind trials of 1,253 patients with episodic migraine. ELYXYB treated patients demonstrated pain relief in as little as 15 minutes and significant pain relief compared to placebo within 45 minutes in nearly 50% of patients. Approximately 36% of patients were pain free at two hours. "We are very excited about the potential of ELYXYB(R) since the launch of the product in April 2023. This is a highly complementary commercial asset that allows us to provide physicians with another tool in their pain management armamentarium to treat migraines earlier in the patient journey as we continue to work towards redefining the role of opioids as a last resort rescue medication," said Jaisim Shah, Chief Executive Officer and President of Scilex.
|
RHHBY NVDA | Hot Stocks09:06 EST Genentech and Nvidia in strategic drug discovery and development AI pact - Genentech, a member of the Roche Group (RHHBY) announced a multi-year strategic research collaboration with NVIDIA (NVDA) that couples Genentech's artificial intelligence AI capabilities, extensive biological and molecular datasets, and research expertise with NVIDIA's world-leading accelerated computing capabilities and AI to speed up drug discovery and development. The collaboration is designed to significantly enhance Genentech's advanced AI research programs by transforming its generative AI models and algorithms into a next-generation AI platform, expediting the discovery and delivery of novel therapies and medicines to people. The companies will join forces to accelerate and optimize Genentech's proprietary machine learning ML algorithms and models on NVIDIA DGX Cloud, which provides a training-as-a-service platform built on dedicated NVIDIA AI supercomputing and software, including NVIDIA BioNemo for generative AI applications in drug discovery. NVIDIA will share its computing expertise with Genentech's teams of computational scientists with the goal of optimizing and scaling Genentech's models, and in that process, may improve or enhance NVIDIA's platforms.
|
HUGE | Hot Stocks09:05 EST FSD Pharma approves plan of arrangement with Celly Nutrition - FSD Pharma announced that the FSD Pharma Securityholders have approved the previously-announced plan of arrangement under section 182 of the Business Corporations Act pursuant to which common shares in the capital of Celly Nutrition Corp., will be distributed to the holders of class A multiple voting shares, class B subordinate voting shares and holders of warrants exercisable for the purchase of class B subordinate voting shares, provided the applicable warrant certificate entitles the holder thereof to receive distributions substantially similar to those received by holders of Class B Shares. Further details regarding the Arrangement are described in the management information circular dated October 20, 2023 and the supplement to the Circular dated November 15, 2023/. At a special meeting of the FSD Pharma Securityholders held earlier, the special resolution to approve the Arrangement was approved by 100% of the holders of Class A Shares and 99.49% of the holders of Class B Shares and FSD Pharma Distribution Warrants that were virtually present or represented by proxy at the Meeting, excluding the votes of holders of securities whose votes are required to be excluded for the purposes of "minority approval" under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions in the context of a "business combination." Subject to the satisfaction of all applicable closing conditions of the Arrangement, the Celly Nu Shares will be distributed to FSD Pharma Securityholders as of the record date of November 28, 2023 on the distribution date of November 29, 2023. The ex-dividend date is November 27, 2023. As disclosed in the Supplement, the Celly Nu Shares that will be distributed to the FSD Pharma Securityholders pursuant to the Arrangement will be subject to restrictions on transfer, such that none of the Celly Nu Shares may be transferred until May 31, 2024, provided that, Celly Nu may, in its sole discretion, waive such restrictions, in whole or in part. The Arrangement remains subject to the satisfaction or waiver of certain other closing conditions customary in a transaction of this nature, including the receipt of a final order from the Ontario Superior Court of Justice approving the Arrangement. The hearing in respect of the Final Order is scheduled to take place on November 24, 2023. Assuming that these remaining conditions to closing are satisfied, the Arrangement is expected to close at or around the end of November 2023.
|
TRMR | Hot Stocks09:03 EST Nexxen launches TV Viewership Audience in U.K., expands offering in U.S. - Nexxen announced the launch of TV Viewership Audiences across the United Kingdom, as well as the expansion of its broader TV Intelligence offering in the United States - a suite of targeting, planning and measurement capabilities, rooted in contextual and exclusive automatic content recognition data. Both the launch and expansion are the result of the consolidation and integration of TV targeting and measurement solutions into the company's Nexxen Discovery platform and demand-side platform.
|
OMF JEF | Hot Stocks09:03 EST OneMain Holdings to acquire Foursight Capital for $115M in cash - OneMain Holdings (OMF) and Jefferies Financial Group (JEF) announced they have reached a definitive agreement under which OneMain will acquire Foursight Capital from Jefferies for $115M in cash. Founded in 2012, Foursight is an automobile finance company that purchases and services automobile retail installment contracts primarily made to near-prime borrowers across 38 states. Contracts are sourced through an extensive network of dealers. As part of the transaction, OneMain will acquire Foursight's approximately $900M loan portfolio. Foursight's approximately 200 employees are expected to join OneMain. The transaction is expected to close in the first quarter of 2024, subject to customary closing conditions and applicable regulatory approvals.
|
AJG | Hot Stocks09:01 EST Arthur J. Gallagher acquires Hughes Insurance Agency - Arthur J. Gallagher acquired Queensbury, New York-based Hughes Insurance Agency. Terms of the transaction were not disclosed. Hughes Insurance Agency provides comprehensive commercial, personal and life & health insurance services to independent businesses and individuals in the Northeastern United States. Linda Abodeely, Joe Koncikowski and their team will continue to operate out of their current location as part of Gallagher Agency Alliance under the direction of Jen Tadin, managing director of Gallagher's Global Small Business practice.
|
F | Hot Stocks08:53 EST Ford authorizes repurchases of up to 51M shares of common stock - In a regulatory filing, Ford Motor disclosed that the company is undertaking a "modest anti-dilutive share repurchase program to offset the dilutive effect of share-based compensation granted during 2023." The plan authorizes repurchases of up to 51M shares of Ford common stock. "The company may repurchase shares of common stock from time to time through open market purchases, in privately negotiated transactions, or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, in accordance with applicable securities laws and other restrictions," the filing stated.
|
MDT | Hot Stocks08:50 EST Medtronic sees Q3 organic revenue growth 4%-4.5% - Says consistently focused on delivering mid single digit revenue growth. Says inflation stabilizing a bit but still higher than historical. Says U.S. dollar has been strong. Says likely facing a headwind from foreign exchange and tax reform. Comments and guidance taken from Q2 earnings conference call.
|
JAGX | Hot Stocks08:49 EST Jaguar Health says top line results for Phase 3 OnTarget trial 'forthcoming' - Napo Pharmaceuticals announced that the company has not yet been provided with results from the company's GCP vendors supporting Napo's pivotal Phase 3 OnTarget trial. The trial is evaluating the company's plant-based prescription drug crofelemer for prophylaxis of diarrhea in adult cancer patients with solid tumors receiving targeted therapy, with or without standard chemotherapy. The top line results of the study are forthcoming. The company's abstract outlining the design of the OnTarget trial and the neglected medical need has been accepted by the December 2023 San Antonio Breast Cancer Symposium. Diarrhea is a common side effect of targeted therapies and new treatments are needed.
|
AIMD | Hot Stocks08:48 EST Ainos reports data from clinical studies for VELDONA - Ainos announced that positive top-line data has been reported from three clinical studies for its VELDONA(R)low-dose oral interferon formulation as a potential treatment for oral warts in HIV-seropositive patients. The positive results partially fulfill the hypotheses of the three studies in establishing a safe daily dose, and demonstrate the formulation's superior efficacy compared to a placebo in relieving oral warts in HIV-seropositive individuals. Based on these results, Ainos plans to pursue a pre-IND meeting with the United States Food and Drug Administration in advance of planned Phase III clinical studies for the drug candidate. A total of 77 HIV-seropositive subjects were enrolled and evaluated between a pilot study and two Phase II clinical studies. Subjects were randomly assigned to either active treatment or placebo groups, with subjects in the active treatment groups received VELDONA lozenges via the oral cavity three times per day for 24 weeks. The placebo subjects were given a matching placebo lozenge at the same interval. After a 24-week treatment, subjects who were administered VELDONA lozenges experienced a reduction of over 75% in the total mucosal surface area covered by oral warts. This was in a significantly greater proportion of HIV-seropositive subjects who are infected with multiple oral warts and who are receiving combination anti-retroviral therapy. Ainos has conducted three trial studies for the treatment of oral warts in HIV-seropositive patients. The first was an open-label pilot study involving 15 HIV-seropositive males with multiple oral warts. The second was a single-blind, dose-ranging study involving 21 HIV-seropositive subjects with multiple oral warts who received a combination anti-retroviral therapy with or without PI. The third was a double-blind, placebo-controlled trial involving a total of 80 HIV-seropositive participants on highly active antiretroviral therapy, randomized to IFN-alpha or placebo for up to 24 weeks. Human immunodeficiency virus, more commonly known as HIV, is a disease which destroys the body's CD4 cells, which are crucial to immune function. It can increase a patient's susceptibility to opportunistic infections such as human papillomavirus, tuberculosis, and fungal and bacterial infections. HPV infection has been identified as the most significant risk factor in the development of oral lesions among the HIV-seropositive population. Viral lesions on the mouth of HIV patients are common and may be indicative of disease progression. Current treatment options for HIV-related oral warts are limited. Pharmacological treatment of intraoral and labial warts is not well-established, with no clinical trials specifically targeting this indication. Only a handful of case reports exist involving the use of drugs such as cidofovir, bleomycin, cimetidine, podophyllum, or intralesional interferon-alpha injections. Oral warts can be surgically removed if they interfere with eating and speaking, or if they are cosmetically displeasing, though surgical removal comes with a risk of local recurrence. The location of the warts and the amount of tissue remaining after removal must also be considered when debating surgical resection.
|
VRAR | Hot Stocks08:46 EST QReal completes paid engagement to create SNAP AR Lens - QReal announced the completion of a paid engagement to create an interactive SNAP AR Lens in partnership with KillaBears and M7 Innovations. This lens has demonstrated extraordinary initial activations while pushing the boundaries of AR and Web3. Leveraging SNAP's new IGLD technology, this interactive KillaBears AR Lens experience offers purchasable upgrades to customize an ultra-realistic Killabears Digital Avatar. Each upgrade aligns with a storyline from the Killaverse folklore, extending the Killabears IP to the SNAP community and allowing to 'embody' a few of the popular Bears from the franchise.
|
AYRO | Hot Stocks08:45 EST Ayro registered on Transport Canada's Appendix G pre-clearance program - AYRO announces that the Company is now registered on Transport Canada's Appendix G Pre-clearance Program as a foreign manufacturer of new Canadian specification low-speed vehicles. As a result, it is now easier for Canadian commercial importers to import new Canadian-compliant AYRO vehicles into Canada. The first of these vehicles, the AYRO Vanish LSEV, entered into low-rate initial production earlier this year after completing all applicable homologation requirements in the United States and Canada, as well as passing California Air Resources Board confirmatory testing.
|
F | Hot Stocks08:45 EST Ford 'pleased' UAW agreement has been ratified - Yesterday, the following statement was issued by Ford President and CEO Jim Farley: "We are pleased the agreement has been ratified and we are very happy for our more than 57,000 UAW-represented employees and their families. Ford believes in rewarding all of our people and growing the middle class in America - and we have shown that with our actions over many years. Now, we are getting back to work as one Ford team. Thankfully, we are on track to reach full production schedules in the coming days at our assembly plants in Michigan, Kentucky and Illinois that were affected during the strike. I'm excited to personally get out to as many of our plants and operations as possible in the coming weeks and months to spend time with our teams who build our vehicles. Ford is America's No. 1 brand again and we want to build on that in 2024. We are entering one of our biggest-ever new product launch years in the U.S. We need to deliver these new vehicles on time and with top quality... All told, we are refreshing about half of our U.S. volume in 2024. We are also working flat out on our next generation of electric vehicles and software platforms. It's also imperative that we continue to attack cost and waste throughout our operations. The reality is that this labor agreement added significant cost, and we are going to have to work very hard on productivity and efficiency to become more competitive." Reference Link
|
BBKCF | Hot Stocks08:44 EST Bigg Digital Assets says Netcoins continues to see 'significant growth' - BIGG Digital Assets is pleased to update investors on its recent trading and platform performance as the crypto market rises. With crypto market conditions steadily improving throughout 2023, Netcoins has seen consistent trading volumes. Most recently, the crypto market has seen significant gains from Bitcoin, Ethereum and a surge amongst a number of alt-coins. With momentum gaining around a number of BTC and ETH ETF Filings in the United States ahead of the April Bitcoin halving, the market is showing signals of renewed interest in crypto trading and investing. Netcoins has continued to see growth in the platforms' Assets under Custody. As of November 15, 2023. Netcoins total Assets under Custody is $81.2 Million. Netcoins has seen double digit growth month over month from September through October, with a rise in AUC of $10M during each month. Monthly trading volumes have increased significantly. In October, Netcoins saw $22M in overall trading volume on the platform. For the first 15 days of November, Netcoins has seen over $25M in trading volume on the platform, and will have its largest volume month of the year. Over $225M worth of crypto assets have been traded on the Netcoins platform year to date, which shows the stability and liquidity of the operation. At the start of October, Netcoins hired Andrew Bulman as its North American Lead for Netcoins OTC Sales and Trading. Just 6 weeks into the launch of the desk Netcoins OTC has seen a deal flow of over $12.6M with significant momentum created heading into the month of November. Netcoins Staking has seen increasing adoption of staking since launching the service on May 31, 2023. As of November 15, 2023, 11.3% of client ETH holdings are staked. This represents a steady increase since June 2023 when Netcoins saw 6.5% of client ETH holdings staked. Netcoins Pay is a free debit card with no credit required allowing registered Netcoins Canada users to make every day purchases using their card wherever Mastercard is accepted. Netcoins offers a 1% Bitcoin reward to its customers for every dollar that they spend using the card. Over $9M has been spent using the Netcoins Pay Mastercard by Canadian users this year, a number that will pass $10M by the end of November. The card has seen strong adoption since its inception and has paid out nearly $55,000 Bitcoin rewards to users for making payments with the card in 2023.
|
OSIS | Hot Stocks08:41 EST OSI Systems receives $5M award for port security solutions - OSI Systems announced that its Security division was awarded a contract valued at approximately $5M from a Latin American customer to provide cargo and vehicle inspection solutions, including installation and integration support. Among the solutions to be provided are the Eagle P60 high-energy, drive-through cargo and vehicle inspection system, Z Portal high-throughput, drive-through inspection system, and the VM500 drive-through radiation monitoring portal.
|
CUEN | Hot Stocks08:40 EST Cuentas releases management update on construction method - Cuentas has released a management update highlighting the use of a pioneering construction method, reminiscent of interlocking LEGO bricks. This method forms entire structures engineered to withstand natural disasters, boasting top-tier ratings for hurricane and earthquake resistance. This marks the initial phase of Cuentas' visionary goal to revolutionize housing affordability through innovative construction practices. In a significant management update, Arik Maimon, CEO of Cuentas, shared insights into the company's triumphant foray into real estate investments and the strategic alliance with RENCO. The completion of its inaugural ninety-six-unit multifamily development using revolutionary construction technology represents a departure from traditional methods. This milestone has garnered extensive media coverage, with a special focus on core products manufactured with naturally occurring raw materials and recycled products in an environmentally friendly process. Maimon, CEO, emphasized, "The investments in Lakewood Village and our new project in Tampa stand as a testament to our management's visionary approach and the strategic selection of this groundbreaking building technology. Our commitment to expanding Cuentas into the lucrative rental income real estate sector is bolstered by the cost-effectiveness and rapid construction capabilities of Renco's technology, ensuring the provision of affordable and quality housing."
|
IGC | Hot Stocks08:39 EST IGC Pharma in pact with University of Los Andes for AI use in drug development - IGC Pharma announced a Master Cooperation Agreement with the University of Los Andes for the development and adoption of generative AI solutions into the Company's drug identification, development, and clinical trial processes. IGC Pharma will be focused on advancing various AI initiatives including: Streamlining clinical trial efficiency: IGC Pharma's leading drug asset, IGC-AD1, is currently in Phase 2 clinical trials for the treatment of agitation related to symptoms of Alzheimer's disease, with four additional assets progressing towards clinical trials. The Company believes that the integration of AI algorithms into clinical trials can significantly enhance trial efficiency including progress, cost reduction, and data analysis. "We are very pleased to be partnering with the University of Los Andes to further our AI initiatives through the development and adoption of AI algorithms that have the potential to significantly enhance the treatment of Alzheimer's disease and other chronic illnesses. We believe that generative AI solutions can have transformative applications for our Company and the drug development industry overall.." The Company is currently pursuing five drug assets targeting the treatment of agitation related to symptoms of Alzheimer's disease. These assets include IGC-AD1, TGR-63, LMP, IGC-1C, and IGC-M3, all of which are currently in different stages of clinical trials and development.
|
SBEV | Hot Stocks08:39 EST Splash Beverage's Copa di Vino, Pulpoloco to be featured in Thornton stores - Splash Beverage announced that Thornton convenience store chain will be featuring Copa di Vino single serve premium wines and Pulpoloco Sangria in Illinois and surrounding areas. The launch will feature varietals of Copa di Vino Premium Wine and varietals of Pulpoloco Sangria. Robert Nistico, Splash Beverage Group's Chairman and CEO, commented, "As we continue to build our foundation of distribution and retail support, this adds to our availability and footprint as we continue our push across the country. The relationship with Thorntons and the parent company, AMPM is extremely valuable to us and supports my statements that the portfolio approach, while takes time to build, is very effective over time and offers the opportunity to add other brands in the portfolio to the mix. We appreciate this authorization very much and wish everyone a very pleasant Thanksgiving!"
|
GPAK | Hot Stocks08:37 EST Gamer Pakistan board authorizes $1M share repurchase program - Gamer Pakistan's Board of Directors has approved a share repurchase program, with authorization to purchase from time to time at the direction of the Board, up to $1.0 million of its common stock. The Share Buyback shall be for the purpose of repurchasing up to $1.0 million of the Company's common stock traded on the NASDAQ Stock Exchange under the ticker symbol "GPAK", pursuant to SEC Rule l0b-18.
|
CASA | Hot Stocks08:36 EST Casa Systems sets cable industry milestone with DOCSIS 4.0 extended spectrum - Casa Systems announced that Casa Systems' Virtual CCAP, vCCAP, coupled with the company's RPD200 solution, has secured a world's first in performance that enables cable modems to achieve full utilization of the extended spectrum available via the DOCSIS 4.0 specification at the recent CableLabs and Kyrio InteropLabs DOCSIS 4.0 Technology event. This successful demonstration showcased the interoperability of Casa Systems' vCCAP and RPD solution with third-party DOCSIS 4.0 cable modems achieving remarkable extended spectrum utilization - up to 1.8 GHz downstream and 396 MHz upstream. This breakthrough not only marks a significant stride in technological innovation but also provides operators with unparalleled flexibility to deploy multi-gigabit broadband services, paving the way for the 10G era. "Through our continuing commitment to innovation in the cable industry sustained over the past 20-plus years, Casa has been helping cable operators move their industry forward," said Casa Systems CEO Michael Glickman. "The unprecedented performance of our market-leading access technologies, including our vCCAP, vBNG and mobile packet cores, will fundamentally shift the competitive landscape across the telecom industry, allowing providers to deliver multi-gigabit services as well as set a sustainable foundation for network evolution as we shift to a virtualized future."
|
NMRD | Hot Stocks08:36 EST Nemaura Medical secures $10M non-dilutive credit facility - Nemaura Medical announced the execution of a strategic agreement for a $10 million credit facility which is expected to support the Company's strategic growth plans. Recognizing the challenges associated with equity sales, particularly in the small-cap landscape on the Nasdaq, Nemaura Medical has proactively pursued a funding strategy that minimizes dilution and, the Company believes, aligns with the best interests of its valued shareholders. This $10 million credit facility, structured to be non-dilutive, empowers the Company to draw down a maximum of $1 million per month, providing a steady and controlled infusion of capital to support Nemaura Medical's commercialization initiatives. The decision to opt for a non-dilutive funding source underscores the Company's commitment to preserving shareholder value in the current market conditions. Dilution has long been a concern for public companies, and the Company believes that this credit facility not only addresses this concern but also positions Nemaura Medical for strategic growth.
|
CETY | Hot Stocks08:35 EST Clean Energy Technologies leads discussion on sustainable energy at APEC - Clean Energy Technologies announced its participation in the Asia Pacific Economic Conference 2023, held in San Francisco. Under the theme "Making Smart Sustainable," CETY's CEO, Kam Mahdi, led discussions focused on forging a resilient and sustainable through technological means. This year's APEC, attended by leaders from its 21 member countries, featured a landmark meeting between Chinese President Xi Jinping and United States President Joe Biden. Their discussion centered on bolstering the sustainability partnership between the world's two largest economies. CEO Kam Mahdi of CETY emphasized the significance of global collaboration in his address: "Achieving a resilient, sustainable future hinges on international cooperation. It's essential for governments to lead the way by implementing supportive policies and incentives that fosters this goal." Over the last five years, CETY has expanded its global footprint, aligning with the cooperative spirit championed at APEC. A testament to this expansion is CETY's partnership with Natural Gas Pipeline Network Group Co., Ltd. in China, reflecting China's shift from coal to renewable energy. This partnership grants CETY access to China's natural gas network. The reach of NGPNG's infrastructure across China not only facilitates CETY's access to international gas imports but also expands the company's sales capabilities through NGPNG's network. To further underscore CETY's dedication to renewable energy initiatives, the company announced a 20-year Power Purchase Agreement in 2023. This agreement, forged between Vermont Renewable Gas, LLC (VRG), a limited liability company affiliated with CETY and VEPP, Inc., a not-for-profit corporation that administers two of Vermont's Renewable Energy Programs under contract with the Vermont Public Utility Commission, involves the sale of all electric power and other related benefits derived from a 2.2-megawatt biogas facility in Lyndonville, Vermont. CETY is set to take the helm in the design, construction, and operational management of this facility, employing its innovative high-temperature ablative fast pyrolysis reactor.
|
ABVC | Hot Stocks08:34 EST ABVC BioPharma receives U.S. patent for ADHD treatment - ABVC BioPharma announced that it received a U.S. patent, Application No. 17/120,965, for the use of PDC-1421, a Radix Polygala extract, which is used in the Company's asset ABV-1505, targeting Attention Deficit/Hyperactivity Disorder, ADHD. "This patent grants ABVC the right to exclude others from using, offering, or selling PDC-1421 throughout the United States until 2040," said Dr. Uttam Patil, ABVC Chief Executive Officer. "As we work towards expanding our patent map into global coverage, we eagerly await the results of patent applications in the European Union, China, Japan, and others." ABVC submitted the patent application to the United States Patent and Trademark Office under "Polygala Extract for the Treatment of ADHD." The invention relates to oral administration of the formulation containing a Radix Polygala extract, PDC-1421, as a capsule for treating ADHD. Based on current studies, the composition should be administered three times a day for eight weeks; each dose ranges between 380-760 mg of the botanical extraction.
|
NNN | Hot Stocks08:34 EST NNN Reit General Counsel Christopher Tessitore to retire, Gina Steffens succeeds - NNN Reit announced that Christopher Tessitore, Executive Vice President and General Counsel, will retire effective January 1, 2024. Gina Steffens will succeed Tessitore as Executive Vice President and General Counsel. Steffens will join the company as of November 30. Steffens joins NNN with extensive public and private company experience. She was most recently CEO of PHM Brands.
|
CYDY | Hot Stocks08:33 EST CytoDyn appoints Jacob Lalezari as interim CEO - CytoDyn announced the appointment of Dr. Jacob Lalezari as interim CEO, effective November 17, 2023. Dr. Lalezari will be responsible for leading the Company's corporate and product development, with a focus on short-term clinical development and related fundraising. Antonio Migliarese, who had been serving as interim president since May 2023, in addition to CFO, will resume his previous role as CFO. Lalezari previously served as interim Chief Medical Officer of CytoDyn during 2020, and has been a member of the Company's scientific advisory board for the past several years. Dr. Lalezari has been the CEO and Medical Director of Quest Clinical Research since 1996/
|
RELI | Hot Stocks08:32 EST Reliance Global announces LOI to acquire benefits enrollment company - Reliance Global Group announced it has entered into a Letter of Intent, LOI, to acquire a well established benefits enrollment company. The Target is a leading provider of voluntary benefits to approximately 45,000 employees throughout the United States and utilizes cutting-edge technology, setting them apart in the industry. The acquisition is subject to the execution of a definitive agreement and other customary closing conditions. The transaction is expected to close in the first quarter of 2024. Ezra Beyman, CEO of Reliance, commented, "We are excited to announce our most significant planned acquisition to date, which would more than double our current revenue and provide attractive EBITDA returns. During fiscal year 2024, the Target is expected to generate over $21 million in revenue, increasing Reliance's expected consolidated revenue by more than 100% to $35 million, which should result in very significant cash flow for the combined companies in 2024 and beyond. This business offers a number of unique voluntary benefits programs across many industries, which will enhance Reliance's overall product offerings. We are very energized about this opportunity and believe that onboarding this target into the Reliance family will provide enhanced synergistic opportunities, in line with Reliance's OneFirm go-to-market platform."
|
DXC HBI | Hot Stocks08:32 EST DXC Technology's workplace solutions selected by Hanesbrands - DXC Technology (DXC) has signed a contract with HanesBrands (HBI) to digitalize the work experience of its thousands of associates around the world. In a five-year deal, HanesBrands will utilize DXC's Modern Workplace solutions to build a digital workplace environment based on ServiceNow and DXC UPTimeTM Device Management technologies. An extension of the two organizations' existing multi-year, global partnership, the new agreement will support the transformation of the mission-critical systems underpinning HanesBrands' business operations spanning 32 countries.
|
RGTI | Hot Stocks08:31 EST Rigetti Computing awarded Phase 2 of DARPA Benchmarking Program - Rigetti Computing was awarded Phase 2 of the Defense Advanced Research Projects Agency Quantum Benchmarking Program to develop benchmarks for quantum application performance on large-scale quantum computers. The award is worth up to $1.5 million based on the achievement of certain milestones. The goal of the DARPA Benchmarking Program is to create key quantum computing metrics for fault tolerant quantum computing, make those metrics testable, and estimate the required quantum and classical resources needed to reach critical performance thresholds. The three-year project comprises two phases. Rigetti was awarded Phase 1 in March 2022, and Phase 2 will be completed in March 2025. The University of Technology Sydney, Aalto University, and the University of Southern California will continue to be project partners in Phase 2. The key output of Phase 1 was the development of a resource estimation framework to provide insight into the requirements of a superconducting quantum computing system necessary for solving large-scale, complex problems. Phase 2 will entail refining and optimizing our estimates for selected utility-scale problems, delivering new upper bounds on these requirements. Another benefit of this resource estimation framework is to enable a cost benefit analysis into whether the resources needed to run a quantum application will be met by the value of solving the particular problem. A challenge in developing quantum algorithms is understanding how a problem will scale, and at what point a dataset is large or complex enough to benefit from the unique properties of quantum computing. Estimating the amount of time, the number of qubits, and the energy required could accelerate the work towards designing an optimized algorithm. Phase 2 will be heavily focused on researching fault-tolerant quantum applications. Of particular interest are dynamical chemistry simulations and modeling the dynamics of quantum systems.
|
PLSE | Hot Stocks08:31 EST Pulse Biosciences files 510k submission with FDA for CellFX nsPFA electrode - Pulse Biosciences announced the filing of a premarket notification 510 k to the U.S. Food and Drug Administration FDA for its novel CellFX nsPFA percutaneous electrode. The Company's percutaneous electrode is an image-guided needle designed to harness CellFX nsPFA energy to deliver precise and complete nonthermal ablation of cellular tissue without damage to noncellular structures. The percutaneous electrode is designed for non-cardiac applications. "We are very happy to make this announcement earlier than expected in part due to the efficiency of the FDA's new electronic submission platform," said Kevin Danahy, President and Chief Executive Officer of Pulse Biosciences. "We look forward to collaborating with the FDA throughout the review process."
|
ZTEK | Hot Stocks08:28 EST Zentek says Albany Graphite Corp. CEO Brian Bosse departs role - Effective November 16, 2023, Brian Bosse has ceased to act as the CEO of Albany Graphite Corp. He will continue to support the Company through his role as a director of Zentek Ltd. Greg Fenton, the CEO of Zentek Ltd. has been appointed as the interim CEO of Albany Graphite Corp.
|
ZTEK | Hot Stocks08:27 EST Zentek provides update on Albany Graphite Project - Zentek provides an update on its wholly owned subsidiary Albany Graphite Corp. On April 25th, 2023, Zentek announced the intention to transfer its 100% owned, Albany Graphite Deposit, a rare hydrothermal graphite deposit located north of Lake Superior and southwest of James Bay in north-eastern Ontario, to a wholly-owned subsidiary, Albany Graphite Corp., and the intention to complete a proposed private placement financing to raise funds for the development of the Albany Graphite Deposit, as well as an intention to potentially list the shares of Albany Graphite Corp. on a recognized Canadian stock exchange. The transfer of the Albany Graphite Deposit was effected on May 19, 2023, and announced in the Company's press release dated May 23, 2023. Since the time of the announcement of the asset transfer and proposed Private Placement, the public market for battery metals and graphite has deteriorated significantly. Management of Zentek and Albany Graphite Corp. have determined to await improved market conditions before proceeding with a Private Placement and/or Listing. Any and all funds that have been received by prospective investors and are currently held in trust pending closing of the Private Placement will be returned to such prospective investors. Management of Zentek continues to believe in the long-term value and potential of the Albany Graphite Deposit and intends to continue to evaluate potential financing and partnership opportunities, as well as to continue engagement with Constance Lake First Nation.
|
CANF | Hot Stocks08:27 EST Can-Fite: Complete response in patient with HCC treated with namodenoson - Can-Fite BioPharma announced that a patient who participated in the Phase II Liver Cancer Study and was treated with namodenoson has a complete response and overall survival of 6.9 years. Liver Cancer designated as hepatocellular carcinoma HCC is a major global health problem due to its incidence, associated mortality, and lack of effective treatment modalities, particularly for patients with advanced hepatic dysfunction known as disease stage Child Pugh B. A patient with advanced HCC that was enrolled in the former Can-Fite Phase II study continues to receive treatment with namodenoson and has now an overall survival of 6.9 years with the disappearance of ascites, normal liver function, and good quality of life and defined as a complete response. Can-Fite has received agreement from both the U.S. Food and Drug Administration FDA and European Medicines Agency EMA on a pivotal Phase III clinical study which is now enrolling patients in Israel, Europe and the US. Namodenoson has Orphan Drug status with both the FDA and EMA, as well as Fast Track Status with the FDA for the treatment of HCC. .."We are currently enrolling patients for the pivotal Phase III clinical study and hope that if the interim analysis data will be positive, we will be able to get a conditional approval, and that patients who suffer from this devastating disease will enjoy our drug," stated Can-Fite CEO Motti Farbstein. According to the American Cancer Society, liver cancer accounts for more than 700,000 deaths globally each year.
|
WAVD | Hot Stocks08:25 EST WaveDancer regains Nasdaq compliance - WaveDancer has received confirmation from The Nasdaq Stock Market that WaveDancer has demonstrated compliance with the requirements to remain listed on the Nasdaq Capital Market. Consequently, WaveDancer is now in compliance with all applicable listing standards, and its common stock will continue to be listed on The Nasdaq Capital Market. The company had previously been notified that it did not meet the $1 minimum bid price requirement and it was out of compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million. On August 8, 2023, WaveDancer presented its plan to regain compliance by effecting a reverse stock split with the minimum bid price requirements and to ensure that its stockholders' equity was above the $2.5 million threshold. On October 18, 2023, WaveDancer effected a one for ten reverse stock split and on October 31, 2023, the Company's stock traded above $1 for the tenth consecutive trading day, as required. On November 13, 2023, the Company filed its Form 10-Q and reported total stockholders' equity above $2.5 million. Nasdaq has informed the Company that it will be subject to a Mandatory Panel Monitor for one year. Upon closing of the recently announced merger of WaveDancer and Firefly Neuroscience, expected in Q1 of 2024, ongoing compliance with Nasdaq listing requirements will be based on Firefly.
|
WMT | Hot Stocks08:20 EST Walmart partners with Bamboo Rose for new enterprise sourcing platform - Walmart announced a joint project with Bamboo Rose to develop and implement an enterprise sourcing platform - ESP - bringing together disparate systems. Through the new ESP, Walmart Sourcing associates around the globe will more easily collaborate with buyers, product development teams and suppliers improving the way the company procures and imports goods for resale. The single sourcing platform creates greater visibility across teams enabling Walmart associates to make more informed purchasing decisions on volume and cost, improving access of goods to other markets and potentially reducing waste in categories such as perishable goods and other sensitive product lines.
|
CMND | Hot Stocks08:15 EST Clearmind Medicine announces 1-for-30 reverse share split - Clearmind Medicine will conduct a reverse share split of its issued and outstanding ordinary shares, no par value, at a ratio of 1-for-30. The reverse split is being effected as part of the Company's plan to regain compliance with the Nasdaq Minimum Bid Price Rule and will be effective commencing November 28, 2023. The reverse share split was approved by the Company's shareholders at the Company's general shareholders meeting held on November 14, 2023 and subsequently resolved by the Company' board of directors. Following the implementation of the reverse split, the Company's authorized share capital will remain unchanged, which as of the date hereof is unlimited. The reverse split will adjust the number of issued and outstanding Common Shares of the Company from 18,221,419 Common Shares to 607,381 Common Shares.
|
INFN | Hot Stocks08:15 EST Infinera awarded California competes grant to increase domestic production - Infinera announced it has been awarded a California Competes grant valued at up to $14M over five years by the California Governor's Office of Business and Economic Development. This is a first step to expand and modernize Infinera's U.S.-based domestic production of next-generation semiconductors and continue to support innovation and economic development in the United States in future years. The CalCompetes grant will enable Infinera, a domestic optical compound semiconductor manufacturer with in-house fab operations and advanced test and packaging capabilities in multiple states, to build upon its 20+ year history in the United States and continue to drive innovation in indium phosphide-based compound semiconductor and monolithic photonic integrated circuit technologies. "We are grateful and honored to receive this grant award, which represents an important step in helping to boost America's domestic production of semiconductor technologies," said David Heard, Chief Executive Officer, Infinera. "Since our founding, we chose to keep our optical compound semiconductor fab and advanced packaging operations in the United States. We remain committed to leveraging our unique expertise, talent, and capabilities to support the goals of U.S. federal and state initiatives focused on economic development and national security."
|
SILO | Hot Stocks08:13 EST Silo Pharma enters exclusive license agreement with Medspray Pharma BV - Silo Pharm announced a new exclusive license agreement with medical technology manufacturer Medspray Pharma BV for its proprietary patented soft mist nasal spray technology, the delivery mechanism selected for Silo's intranasal therapeutic drug SPC-15. "We began a collaboration with Medspray earlier this year for feasibility studies evaluating its patented technology as a delivery mechanism for our intranasal therapeutic drug SPC-15. Based on successful outcomes from these studies, we have selected Medspray's Spray Technology for our formulation," said Eric Weisblum, Chief Executive Officer of Silo Pharma. "As part of our manufacturing and sales contract, we have obtained exclusive rights to its spray mist technology for use with multiple indications including post-traumatic stress disorder and anxiety, as well as Alzheimer's disease and anorexia. We believe these rights are a valuable asset that can support Silo's continuing research and development of novel therapeutics."
|
DCFC | Hot Stocks08:11 EST Tritium supplies rapid chargers for Wales' largest EV charging facility - Tritium DCFC announced that the company will provide the rapid chargers for Wales' largest EV charging facility. With this new charging site, locals, visitors, and National Library of Wales staff in Aberystwyth will gain access to Wales' largest EV charging site, thanks to a new hub with 40 charging points - including five rapid Tritium 75kW DC chargers with 10 connectors - at the National Library of Wales. The charging hub will benefit local EV owners, including customers of nearby towns and villages, as well as attract tourists who are either visiting or passing through Aberystwyth. This rollout will allow EV drivers to visit the retail site and browse the library while they wait for their EV to complete a charge cycle, which in turn will increase visitors through the library's doors to support the local institution. "While the UK Government has now confirmed plans to ban the sale of new petrol and diesel vehicles by 2035, the rollout of EV charging infrastructure must continue to accelerate to meet their target to install 300,000 public charging stations by 2030. Wales has a major role to play in this acceleration so that the whole of the UK transport network is electrified, allowing drivers to traverse the country," said Tritium CEO Jane Hunter.
|
RSLS | Hot Stocks08:11 EST ReShape Lifesciences enters warrant exercise transaction for $1.2M - ReShape Lifesciences, has entered into a warrant exercise agreement with an existing accredited investor to exercise outstanding warrants to purchase an aggregate of 5,382,500 shares of the company's common stock. In consideration for the immediate exercise of the existing warrants for cash, the exercising holder received new unregistered warrants to purchase up to an aggregate of 10,765,000 shares of the company's common stock. In connection with the exercise, the company also agreed to reduce the exercise price of the 5,382,500 exercised warrants and 6,960,351 remaining unexercised warrants to $0.23, which is equal to the most recent closing price of the company's common stock on The Nasdaq Capital Market prior to the execution of the warrant exercise agreement. The new warrants will become exercisable six months following issuance at an initial exercise price of $0.23 per share, which is subject to reduction as set forth in the new warrants if approved by the Company's stockholders in accordance with the rules of the Nasdaq Stock Market, and have a term of exercise equal to five and one-half years. The company agreed to file a resale registration statement within 30 days with respect to the new warrants and the shares of common stock issuable upon exercise of the new warrants and to hold a meeting of its stockholders to seek approval of the potential reduction of the exercise price of the new warrants. The warrants being exercised and the new warrants each include a beneficial ownership limitation that prevents the investor from owning more than 9.99%, with respect to the existing warrants, and 4.99%, with respect to the new warrants, of the company's outstanding common stock at any time. The gross proceeds to the company from the exercise of the existing warrants was approximately $1.2 million, prior to deducting placement agent fees and estimated offering expenses. The company intends to use the net proceeds for commercial growth, working capital and general corporate purposes. Maxim Group LLC acted as the exclusive warrant inducement agent and financial advisor for the transaction.
|
ONFO | Hot Stocks08:10 EST Onfolio launches DealPipe off-market deal origination service - Onfolio Holdings announces the launch of DealPipe, a service for sourcing "off-market" acquisition targets. Dealpipe.io launched on Friday November 17th and received dozens of inquiries in the first 24 hours of going live. The team are excited about the opportunities to help serial acquirers find online or offline businesses to add to their portfolios, and to help business owners find good homes for their businesses. For their efforts, the Dealpipe team will earn monthly retainers, plus a success fee based on a percentage of the successful acquisition price, creating a lucrative business model.
|
LABP | Hot Stocks08:08 EST Landos Biopharma publishes results of NX-13 Phase 1b study in UC - Landos Biopharma announced a peer-reviewed publication describing the safety, tolerability, pharmacokinetic and clinical efficacy results for the NX-13 Phase 1b trial in patients with ulcerative colitis, UC, in the Journal of Crohn's and Colitis. "We are delighted to have our Phase 1b results of NX-13 in UC published in the Journal of Crohn's and Colitis," said Dr. Fabio Cataldi, Executive Vice-President & Chief Medical Officer at Landos. "The publication highlights the promising data that are the foundation for our ongoing NEXUS Phase 2 trial, which is on track for top-line readout in the fourth quarter of 2024." The publication, titled "The Safety, Tolerability, Pharmacokinetics and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study", reports the results of the Phase 1b trial which included 38 patients randomized to placebo, 250mg immediate release of NX-13, 500mg IR of NX-13 or 500mg delayed release NX-13. NX-13 was found to be well tolerated in all patients studied. No deaths or severe adverse events were reported and all adverse events were mild to moderate. The majority of patients treated with NX-13 for four weeks showed consistent and rapid clinical improvement in total Mayo score and in symptoms relief. Additionally, the endoscopic improvement observed correlated closely with symptoms improvement. NX-13 is currently being evaluated in the NEXUS trial, a randomized, multicenter, double-blind, placebo-controlled, multiple dose, statistically powered, Phase 2 proof-of-concept study with top-line results expected in the fourth quarter of 2024.
|
PRST | Hot Stocks08:08 EST Presto Automation appoints Steve Herbert as advisor for Presto Touch - Presto Automation has appointed Steve Herbert as a Strategic Advisor for Presto Touch, Presto's at-the-table self-serve payment and ordering technology business line. Steve was previously the Chairman and CEO of USA Technologies, a public company focused on hardware and software payments solutions for the retail industry. In the strategic advisor role, Steve is working closely with Presto's leadership to seek to transition existing customers to Presto Touch next-generation Flex product and to define a product strategy that maximizes shareholder value. This is in furtherance of the previously announced consideration of strategic alternatives for Presto Touch solution and evaluation of which path makes best sense for shareholders.
|
MDGL MRNA | Hot Stocks08:06 EST Madrigal Pharmaceuticals appoints Ronald Filippo as CIO - Madrigal Pharmaceuticals (MDGL) announced that Ronald Filippo has been appointed Chief Information Officer. Filippo has more than 25 years of digital experience in the biopharmaceutical industry and was previously Senior Vice President Digital at Moderna (MRNA), where he was responsible for technology leadership and digital transformation across core operations during the commercialization of the company's COVID-19 vaccine.
|
BAER | Hot Stocks08:06 EST Bridger Aerospace announces pending closure of Spanish Scooper transition - Bridger Aerospace Group announced that it has entered into a joint venture partnership to complete the purchase of four Canadair CL-215T Amphibious Aircraft recently awarded in a public tender process from the Government of Spain for EUR 40.3 million. The purchase by the partnership, which brings together Marathon Asset Management LP, Avenue Sustainable Solutions Fund, and Bridger, is expected to formally close in ten business days. "Bridger's mission is to support communities affected by wildfires wherever they occur. There is global demand for specialty aircraft like the CL-215T, and with the addition of these airframes we are positioned to operate the largest privately owned scooper fleet in the world. Our access to these aircraft represents a strategic and transformative step for Bridger and positions us to expand our customer base and create substantial revenue and cash flow growth for the next several years," commented Tim Sheehy, Bridger's Chief Executive Officer. The terms of the agreement entered into between Bridger and the partnership provide that Bridger will manage the return to service upgrades of the planes while they are owned and funded by the partnership. Bridger has the right, but not the obligation, to acquire each plane as it is ready to be contracted and returned to service. Bridger plans to acquire the aircraft in a sequential manner as they are modified and subsequently contracted for service. Bridger expects the first two Scoopers to be ready for contract operations in the Summer of 2024 in the European Union. The return to service work on the third and fourth Scoopers is expected to commence once Bridger acquires the first two modified and contracted Scoopers from the partnership.
|
ACRV | Hot Stocks08:04 EST Acrivon Therapeutics announces inducement grant under Nasdaq listing rule - Acrivon Therapeutics announced that the company approved a grant of equity award under its 2023 Inducement Plan to one employee. The equity award was granted in the form of stock options and has a grant date of November 17, 2023. The employee received options to purchase 57,900 shares of Acrivon common stock. The stock options will vest 25% on the first anniversary of the first day of the month following the effective date of such employee's employment and the remaining options shall vest over a three-year period, on a monthly basis, a rate of 2.083%, subject to continued employment on each vesting date. The inducement grant was approved by Acrivon's board of directors, as required by Nasdaq Rule 5635(c)(4), and was granted as a material inducement to employment in accordance with Nasdaq Rule 5635(c)(4).
|
THO | Hot Stocks08:03 EST Thor Industries launches EV charging stations for electric RVs - Thor Industries unveiled 3-D renderings of an EV charging station concept designed to serve the comprehensive needs of electric recreational vehicles - eRVs -. The concept illustrates Thor's efforts to support the development of pull-through eRV-compatible chargers in destinations popular with RV owners. In addition to the design and development of the charging station concept, the company is supporting the RV Industry Association's effort to encourage federal and state governments to invest in the installation of eRV-compatible stations. The EV charging station concept incorporates beautiful natural landscaping, berms, trees and green spaces since EV charging stations doesn't store or handle fuel. The charging station concept is based on best practices developed by the engineering firm Black & Veatch. The ideas were first outlined in a recent white paper commissioned by THOR and the RV Industry Association detailing the economic case for states to use some of the $7.5B federal EV funding currently available to state and tribal governments to build eRV-compatible pull-through charging stations.
|
CVU ERJ | Hot Stocks08:02 EST CPI Aerostructures receives $4.4M orders from Embraer - CPI Aerostructures (CVU) announced that Embraer S.A. of Brazil (ERJ) has placed several additional orders against a previously announced Long Term Agreement to manufacture engine inlet assemblies for the Embraer Phenom 300 business jets. These new orders will see deliveries continue into 2024. "CPI Aero is proud to be part of the successful Phenom 300 program where we continue to demonstrate our capabilities in assembly & integration of complex, mixed-commodity Aerostructures. During the last 10+ years, we have delivered over 1,600 Engine Inlet Assemblies and fully expect to continue serving this important customer beyond 2024," stated Dorith Hakim, CPI Aero's CEO & President.
|
GDC | Hot Stocks08:02 EST GD Culture Group enters MoU with Pier E Media for expansion into TikTok - GD Culture Group announced the signing of a Memorandum of Understanding between AI Catalysis and Pier E Media, a leading influencer agency that connects brands with influential content creators, to expand its agency business on TikTok. The collaboration marks GDC's strategic expansion into TikTok agency business, which is critical in boosting the Company's performance in eCommerce and game live streaming sectors and strengthening its connections with TikTok content creators. Pursuant to the MOU, AI Catalysis and Pier E Media shall act as the Movement directors. Additionally, Pier E Media grants the rights to AI Catalysis to utilize its agency license and TikTok accounts. The signing of the MOU is essential to the AI Catalysis's talent acquisition and business expansion. Xiaojian Wang, Chairman and Chief Executive Officer of the Company, expressed his enthusiasm for the collaboration: "We are excited to announce our partnership with Pier E Media, which not only positions us as a premier TikTok agency but also underscores our commitment to nurturing stronger relationships with creators. This collaboration showcases our dedication to reshaping influencer marketing and empowering TikTok content creators. We are dedicated to providing creators with the tools they need to excel in the digital landscape."
|
AVGO VMW | Hot Stocks07:55 EST Broadcom intends to close VMware acquisition on November 22 - Broadcom (AVGO) and VMware (VMW) announced that they have received all required regulatory approvals and intend to close Broadcom's acquisition of VMware on November 22. Broadcom has received legal merger clearance in Australia, Brazil, Canada, China, the European Union, Israel, Japan, South Africa, South Korea, Taiwan, the United Kingdom, and foreign investment control clearance in all necessary jurisdictions. There is no legal impediment to closing under U.S. merger regulations.
|
BDRBF | Hot Stocks07:51 EST Bombardier announces expiration of early tender date for cash tender offer - Bombardier announced certain matters with respect to its cash tender offer previously announced on November 6, 2023 to purchase for cash up to $360,000,000 aggregate purchase price of its outstanding 7.125% Senior Notes due 2026 and its outstanding 7.875% Senior Notes due 2027, subject to possible proration and other terms and conditions set forth in the Offer to Purchase. Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Offer to Purchase dated November 6, 2023 with respect to the Tender Offer. Based upon the aggregate principal amount of 2026 Notes that were validly tendered and not validly withdrawn as of the Early Tender Date, the proration factor with respect to the 2026 Notes is approximately 22.43%. Based upon the aggregate principal amount of 2027 Notes that were validly tendered and not validly withdrawn as of the Early Tender Date, the proration factor with respect to the 2027 Notes is approximately 13.00%. An amount of 2026 Notes equal to the 2026 Tender Cap and an amount of 2027 Notes equal to the 2027 Tender Cap, in each case that were validly tendered and not validly withdrawn at or before the Early Tender Date, will be accepted for purchase by Bombardier on the Early Settlement Date. All such Notes that have been accepted will be settled on the Early Settlement Date in accordance with the terms of the Tender Offer as set forth in the Offer to Purchase, including proration with respect to both the 2026 Notes and 2027 Notes. Bombardier expects such Early Settlement Date to be November 24, 2023. On the Early Settlement Date, the aggregate total purchase price payable under the Offer to Purchase for Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date and accepted for purchase will have reached the Aggregate Maximum Purchase Amount, the 2026 Tender Cap with respect to the 2026 Notes and the 2027 Tender Cap with respect to the 2027 Notes. As a result of the amount of 2026 Notes and 2027 Notes accepted for purchase on the Early Settlement Date, no Notes tendered after the Early Tender Date will, under the terms of the Offer to Purchase, be accepted for payment unless, in the Corporation's sole and absolute discretion, the terms of the Tender Offer are further amended or waived by the Corporation to permit further purchases of the 2026 Notes or 2027 Notes. There can be no assurance that the Corporation will further amend or waive any terms of the Tender Offer to accept any Notes tendered after the Early Tender Date or amend the Tender Offer in any other respect.
|
AVGO VMW | Hot Stocks07:46 EST Broadcom, VMware intend to close transaction on November 22 - Broadcom (AVGO) and VMware (VMW) announced that they have received all required regulatory approvals and intend to close Broadcom's acquisition of VMware on November 22. Broadcom has received legal merger clearance in Australia, Brazil, Canada, China, the European Union, Israel, Japan, South Africa, South Korea, Taiwan, the United Kingdom, and foreign investment control clearance in all necessary jurisdictions. There is no legal impediment to closing under U.S. merger regulations.
|
NOG | Hot Stocks07:38 EST Northern Oil and Gas announces bolt-on acquisitions, expected to be accretive - Northern Oil and Gas announced two acquisition transactions. NOG has entered into a definitive agreement with a private party to acquire non-operated interests across ~3,000 net acres located primarily in Lea and Eddy Counties, New Mexico. NOG owns existing interests in approximately 90% of the leasehold. Current production is ~2,800 Boe per day or 2-stream, ~67% oil. NOG expects 2024 production to average ~2,500 Boe per dayor 2-stream, ~67% oil, but expects significant future growth on the assets, with average production of greater than3,500 Boe per day for 2025 through 2030. Capital expenditures on the assets are expected to be in the range of $25 - $30M to be incurred in 2024, with similar expected levels annually through 2027...The effective date for the transaction is November 1.. NOG has placed a $17.1M deposit for the acquisition with the balance of the funding to occur at closing, which is expected in the first quarter of 2024, subject to the satisfaction of typical closing conditions..."These transactions demonstrate our continued ability to successfully acquire high quality assets in the core of their respective basins, with best-in-class operating parties," commented Nick O'Grady, Chief Executive Officer of NOG. "We expect the assets to be accretive in 2024 and to accelerate further in future years. We are also pleased to expand our Appalachian presence into some of the best parts of the Ohio Utica Shale as we continue to grow our natural gas portfolio in the region over time. Notably, at the current pricing strip, we still expect to reach our ~1x leverage ratio target in 2024 and cash generating assets such as these should add to dividend capacity over time." "After closing, our Permian lands will approach ~40,000 net acres and definitively become our most active and largest basin in terms of activity and production," commented Adam Dirlam, NOG's President.
|
GPAC SDST | Hot Stocks07:35 EST Stardust Power to become public through Global Partner Acquisition combination - Stardust Power, a development stage American manufacturer of battery-grade lithium products, and Global Partner Acquisition (GPAC), a publicly traded special purpose acquisition company, or SPAC, announced it has entered into a definitive agreement for a business combination that would result in Stardust Power becoming a publicly listed company on Nasdaq under the new ticker symbol (SDST). The implied pro forma enterprise value of Stardust Power is expected to be $490M. Stardust Power's existing owners and management will roll 100% of their interests in Stardust Power into the combined company. The existing Stardust Power leadership team is expected to remain in place and will continue to execute the company's strategy.
|
GPAC | Hot Stocks07:34 EST Stardust Power to become public through Global Partner Acquisition combination - Stardust Power, a development stage American manufacturer of battery-grade lithium products, and Global Partner Acquisition (GPAC), a publicly traded special purpose acquisition company, or SPAC, announced it has entered into a definitive agreement for a business combination that would result in Stardust Power becoming a publicly listed company on Nasdaq under the new ticker symbol (SDST). The implied pro forma enterprise value of Stardust Power is expected to be $490M. Stardust Power's existing owners and management will roll 100% of their interests in Stardust Power into the combined company. The existing Stardust Power leadership team is expected to remain in place and will continue to execute the company's strategy.
|
RVVTF | Hot Stocks07:33 EST Revive Therapeutics provides update on Bucillamine formulation development - Revive Therapeutics provides an update on the development of a next generation lyophilized formulation of Bucillamine. Under an agreement with the University of Waterloo, formulation development work is ongoing and is expected to be completed by the end of the year. The research team has improved the solubility of Bucillamine and subsequent lyophilization has resulted in more than double enhancement of solubility, which would unlock the therapeutic utility of Bucillamine for public health medical emergencies, including pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. Specifically, the novel Bucillamine formulation could support the continuation of the research project the Company has with the Defence R&D Canada - Suffield, an agency of the Canadian Department of National Defence, to evaluate Bucillamine as a potential treatment for nerve agent exposure. The Company expects to have its novel lyophilized formulation of Bucillamine ready for production with a contract development manufacturing organization for clinical evaluation in 2024.
|
TMC | Hot Stocks07:32 EST Metals Company commends U.S. Senators' push to ratify UNCLOS - TMC commends an initiative by U.S. Senators for the country to ratify UNCLOS - which it signed in 1982 but has since failed to ratify - in part to assert a leadership role in the global effort to govern the high seas and shore up supply chains for the critical battery materials required for the energy transition. TMC CEO & Chairman Gerard Barron said, "It's encouraging to hear policymakers calling for the world's largest economy to play an active role in shaping the rules for the responsible development of marine resources in the high seas. The U.S. faces an acute shortage of domestic supply and processing of critical lithium-ion battery cathode materials like cobalt, nickel and manganese. We recognize the longer-term opportunity that polymetallic nodules represent for the U.S. and - whether the country ultimately ratifies UNLCOS or not - we will continue to work with American policymakers, companies and researchers to determine a role for nodules in achieving the country's clean energy ambitions."
|
ANGH | Hot Stocks07:29 EST Anghami to combine business with OSN+ platform including $50M investment - Anghami and OSN+, a streaming platform in the Middle East and North Africa for premium content, have announced a deal that will combine their businesses. The combination of the two brands will offer consumers digital aggregation of movies, TV shows, music, podcasts and more. Backed by a cash investment of up to $50M from OSN Group in Anghami, the deal will bring together over 120 million registered users, more than 2.5 million paying subscribers with over $100M in revenue at closing. Anghami's catalogue has over 100 million songs, while OSN+ has over 18,000 hours of video content and exclusive partnership with international studios such as HBO, NBC Universal, Paramount, and leading Arabic and Turkish studios. The platform will leverage Anghami's tech stack and music catalogue coupled with OSN+'s library of video content. The OSN Group will invest in Anghami at a valuation of $3.65 per share, 3.9x the stock's average price for the past month. Anghami intends to maintain the listing of its ordinary shares on the Nasdaq Stock Market following the closing of the transaction. The transaction is expected to close in 1Q24, subject to customary closing conditions and regulatory approvals. Following the closing of the transaction, OSN Group will own a majority stake in Anghami. In addition to its stake in Anghami, OSN will continue to run its linear TV business OSNtv, with Joe Kawkabani as Group CEO.
|
DKS | Hot Stocks07:18 EST Dick's Sporting jumps 8% to $129.02 after Q3 results beat, FY23 guidance raised
|
NXHSF | Hot Stocks07:10 EST Next Hydrogen Solutions, GE Vernova sign MoU - GE Vernova's Power Conversion business and Next Hydrogen Solutions have signed a memorandum of understanding to integrate Next Hydrogen's electrolysis technology with GE Vernova's power systems offerings to produce green hydrogen. The integration of GE Vernova's power conversion technology provides Next Hydrogen water electrolyzers with direct current power sourced from renewable energy, including solar, wind, and hydro. GE Vernova's Power Conversion will integrate DC power supplies along with power quality such as synchronous condensers, energy storage, motors and drives for compression and water, and controls with Energy Management. "Next Hydrogen is pleased to partner with GE Vernova given its established market channels, broad ability to reach a large number of customers, and its solid track record on project delivery and execution," said Raveel Afzaal, president and CEO of Next Hydrogen. "Our partnership with GE Vernova supports Next Hydrogen's commitment to pioneering innovative green hydrogen technologies, addressing climate change, and promoting global energy sustainability for a cleaner future," he added. In its inaugural phase, GE Vernova and Next Hydrogen plan to pioneer advanced power systems that align with the forthcoming generation of Next Hydrogen electrolyzers, which are scheduled to launch in 2024. This collaborative effort will encompass installation, rigorous testing, and the seamless integration of a Next Hydrogen water electrolyzer with a power supply meticulously designed and fabricated by GE Vernova.
|
TAC | Hot Stocks07:09 EST TransAlta sees 2024 adjusted EBITDA $1.15B-$1.3B - Sees 2024 FCF $450M-$600M or FCF per share $1.45-$1.94..
|
EGLXF | Hot Stocks07:08 EST Enthusiast Gaming's U.GG launches VALORANT desktop app - Enthusiast Gaming has launched a stand-alone desktop application in support of VALORANT, one of the fastest growing competitive FPS titles in the world. U.GG averages 10 million users per month as a go-to resource for League of Legends and World of Warcraft players, with more than 1.9 million players already having downloaded U.GG's stand-alone League of Legends desktop applications. This expansion into VALORANT further solidifies U.GG's position as the dominant multi-title gaming community and insights platform while providing U.GG with deep insights into the predominantly Gen Z playerbase. "VALORANT is becoming one of the next great competitive titles, and we are happy to provide support to their millions of players from around the world," said Nick Brien, CEO of Enthusiast Gaming. "Not only does our expansion into VALORANT strategically align with our commitment to fostering a thriving gaming ecosystem and ensuring that our users have access to the latest and most relevant data, but it also provides a tremendous opportunity for U.GG to become a mainstay companion app for one of the fastest growing games in North America, much as it has done before with League of Legends."
|
TAC | Hot Stocks07:08 EST TransAlta increases common share dividend 9% to 6c per share - TransAlta has approved a 2c annualized increase to the common share dividend, or 9% increase, and declared a dividend of 6c per common share to be payable on April 1, 2024 to shareholders of record at the close of business on March 1, 2023. The quarterly dividend of 6c per common share represents an annualized dividend of 24c per common share.
|
DKS | Hot Stocks07:07 EST Dick's Sporting sees FY23 CapEx $670M-$720M on gross basis - Sees FY23 CapEx $550M-$600M on net basis.
|
MDWD ENLV | Hot Stocks07:07 EST MediWound appoints Hess as Chief Operating Officer, Chief Commercial Officer - MediWound (MDWD) announced the appointment of Shmulik Hess, Ph.D. to the positions of Chief Operating Officer and Chief Commercial Officer effective as of December 1, 2023. Dr. Hess will lead and oversee all operational and commercial activities at MediWound. Prior to joining MediWound, he served as Chief Executive Officer at Tabby Therapeutics, Enlivex Therapeutics (ENLV), and Valin Technologies.
|
DKS | Hot Stocks07:06 EST Dick's Sporting sees additional pre-tax charges of $10M in Q4 - As previously announced, the company is conducting a business optimization to better align its talent, organizational design and spending in support of its most critical strategies while also streamlining its overall cost structure. During the third quarter of 2023, the company incurred pre-tax business optimization charges of $52.5M related to the elimination of certain positions primarily at its customer support center as well as the integration of its Moosejaw operations and other charges to optimize the cost structure of its outdoor specialty business. The company currently anticipates additional pre-tax charges of approximately $10M during the fourth quarter of 2023 related to its actions to optimize the outdoor specialty business and plans to continue its business optimization review, which it expects to complete during fiscal 2023.
|
MDWD | Hot Stocks07:06 EST MediWound expects cash to fund operating plan through profitability - As of September 30, 2023, the Company's cash, restricted cash, and investments were $46 million, compared to $34.1 million reported on December 31, 2022. In the first quarter of 2023, the Company raised a gross amount of $27.5 million through a registered direct offering. During the third quarter of 2023, the Company used $5.4 million to fund its activities. Existing cash and cash equivalents are expected to provide sufficient funds for the Company's current operating plan through profitability. The Company's issued and outstanding shares of NIS 0.07 par value as of December 31, 2022, June 30, 2023, and September 30, 2023, were 7,240,020, 9,216,520 and 9,219,261, respectively.
|
WH CHH | Hot Stocks07:05 EST Choice Hotels letter a 'step backwards,' says Wyndham Hotels board - Wyndham Hotels & Resorts (WH) announced that its Board of Directors received a letter from Choice Hotels International, Inc. (CHH), on November 14, 2023. Wyndham's Board of Directors, together with its financial and legal advisors, closely reviewed Choice's letter and determined that it represents a step backwards and that the terms Choice outlined are not in the best interests of Wyndham or its shareholders. Choice's first communication in a month since its public disclosure of its unsolicited proposal contains no change to the form of consideration and continues to undervalue Wyndham's standalone growth prospects. At Choice's current share price, its offer to acquire all outstanding shares of Wyndham stands at a value of $86 per share, below the nominal value of $90 per share proposed on October 17, 2023, the date of Choice's public disclosure. The letter proposes a two-year period for Choice to seek to obtain regulatory approvals supported only by a low 6% reverse termination fee, which would both create a prolonged period of limbo and expose Wyndham and its shareholders to significant asymmetrical risk. Stephen P. Holmes, Chairman of the Wyndham Board of Directors, said, "Choice continues to ignore our major concerns around value, consideration mix, and asymmetrical risk to our shareholders given the uncertainty around regulatory timeline and outcome. In addition, Choice's existing proposal is valued at $86 per share, lower than the unsolicited public proposal of $90 per share they made a month ago. Given they now explicitly acknowledge the legitimate issues around the regulatory timeline, they are essentially asking our shareholders to take on serious risk and accept as compensation for a failed deal a low reverse termination fee that doesn't even begin to compensate for the potential lost earnings and long-term impairment to value that could occur during an uncertain two-year regulatory review. In line with our fiduciary duties, we will of course always evaluate any serious proposal, but Choice continues to fail to adequately address any of the three core issues we have repeatedly raised. They have instead chosen to prolong this for months with a proposal that remains unfeasible, damaging to our business, and unnecessarily distracting to our management team."
|
LTRX | Hot Stocks07:05 EST Lantronix appoints Saleel Awsare to its board of directors - Lantronix announced that Lantronix president and CEO Saleel Awsare has joined the Company's Board of Directors, effective Nov. 20, 2023. With the appointment of Awsare, the Board consists of five directors, four of whom the Board has determined are independent under applicable listing standards of the NASDAQ Stock Market. In connection with the commencement of his employment as president and CEO, the Company has agreed to issue Awsare inducement awards consisting of 470,255 restricted share units, 235,127 performance share units tied to the same vesting requirements as the Company's PSUs granted to its executive officers for fiscal 2024 and 223,931 PSUs tied to the Company's relative total stockholder return (TSR), with the number of PSUs assuming target level of performance for each grant.
|
DKS | Hot Stocks07:04 EST Dick's Sporting CEO says 'We are pleased with our third quarter results' - Lauren Hobart, President and CEO said, "We are pleased with our third quarter results. With our best-in-class athlete experience and differentiated assortment, we had a very strong back-to-school season and continued to gain market share as consumers prioritize DICK'S Sporting Goods to meet their needs. Our Q3 comps were driven by increases in both transactions and average ticket, and we delivered double-digit EBT margin on a non-GAAP basis. As a result of our strong Q3 performance, we are raising our full year outlook, which balances the confidence we have in our key strategies with an acknowledgment of the uncertain macroeconomic environment. We're excited for the upcoming holiday season and the product, service and experience we are providing to our athletes." Ed Stack, Executive Chairman said, "Our strong Q3 comps demonstrate the impact of our strategies and our commitment to innovation. We are confident in the future of our business and believe our results demonstrate how we are successfully differentiating ourselves in the marketplace."
|
BBY | Hot Stocks07:04 EST Best Buy sees Q4 comparable sales down 3%-7% - Best Buy CFO Matt Bilunas said, "For the fourth quarter, we expect our comparable sales to decline in the range of 3.0% to 7.0%. On the profitability side, we expect our Q4 FY24 non-GAAP operating income rate to be in a range of 4.7% to 5.0%, which compares to a rate of 4.8% last year."
|
CLMB | Hot Stocks07:04 EST Climb Global announces partnership with Security Compass - Climb Channel Solutions, a wholly owned subsidiary of Climb Global Solutions, announces a partnership with pioneer in application security, Security Compass. This collaboration marks a significant milestone as Security Compass commits to amplifying its channel presence worldwide, with Climb Channel Solutions selected as their preferred distributor. Security Compass is committed to providing a holistic approach to software by design, enabling Climb's resellers and their customers to learn, automate, develop applications while maintaining security and compliance. "Climb Channel Solutions is proud to partner with Security Compass and be their choice distributor worldwide," says Dale Foster, CEO of Climb Channel Solutions. "We are excited to provide our global reseller partners with offerings from a pioneer in application security while simultaneously helping Security Compass navigate the channel landscape. Security Compass' goals to maintain security and compliance aligns with Climb's dedication to our partner base to offer the best in emerging technology without sacrificing these primary values."
|
WH CHH | Hot Stocks07:04 EST Wyndham Hotels & Resorts board determines new Choice letter is 'step backwards'
|
BCRX | Hot Stocks07:02 EST BioCryst launches ORLADEYO in Spain - BioCryst Pharmaceuticals announced that the Spanish Ministry for Health has granted marketing authorization for oral, once-daily ORLADEYO for the routine prevention of recurrent hereditary angioedema, HAE, attacks in HAE patients 12 years and older. "We have an experienced and motivated team in Spain that is enthusiastic about the impact the availability of the first oral, once daily therapy can have for people with HAE in Spain," said Charlie Gayer, chief commercial officer of BioCryst. "Spanish patients and physicians have shared with us the need to expand treatment options and we are excited now to be in a position to support access to those who can benefit most."
|
ECX | Hot Stocks07:02 EST Ecarx starts mass production of Antora 1000 computing platform for Lynk & Co SUV - ECARX Holdings announced that the Lynk & Co 06 EM-P SUV, featuring a digital cockpit experience powered by the ECARX Antora 1000 computing platform, has entered mass production. This marks another significant milestone in the strategic partnership between ECARX and Lynk & Co, following the recent debut of the Lynk & Co 08 EM-P SUV, the first vehicle to launch with ECARX's full-stack solution including the ECARX Antora 1000 Pro digital cockpit computing platform. The ECARX Antora 1000 elevates cockpit convenience and safety to new heights in the Lynk & Co 06 EM-P SUV, powering a 14.6-inch floating central control screen and a 10.2-inch TFT instrument cluster to support a diverse range of interactive functions and immersive experiences, from online navigation and voice command features to karaoke and e-sports.
|
DOYU | Hot Stocks06:58 EST DouYu announces CEO Shaojie Chen arrested - DouYu announced that the company was informed on November 20 that Shaojie Chen, the CEO and the chairman of the board of the directors of the company, was arrested by the Chengdu police on or about November 16. The company has not received any official notice of the investigation against Chen or the reasons for Chen's apparent arrest. The company cannot comment on the nature or expected timeline of subsequent legal proceedings, if any, that may follow. Chen's ongoing detention and any subsequent related legal proceedings and enforcement actions against the parties involved may have a material adverse impact on the company's reputation, business and results of operations. The company maintains normal operation of its business and remains committed to upholding regulatory compliance on its platform. The Board and management will supervise the operations of the company and work on contingency plans in response to Chen's arrest and related investigations.
|
BDX | Hot Stocks06:56 EST Becton Dickinson names Ronald Silverman chief medical officer - Becton Dickinson announced that Ronald Silverman has been named executive vice president and chief medical officer of BD, effective December 4. Silverman will be responsible for leading the company's Medical Affairs organization, which includes end-to-end medical affairs across BD's business units, regions and central team. Silverman will report to Beth McCombs, executive vice president and chief technology officer for BD, and serve as a member of the BD executive leadership team.
|
MRK | Hot Stocks06:46 EST Merck to acquire Caraway Therapeutics for up to $610M - Merck and Caraway Therapeutics announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Caraway Therapeutics for a total potential consideration of up to $610M, including an undisclosed upfront payment as well as contingent milestone payments. The upfront payment will be expensed by Merck in the fourth quarter of 2023 and included in non-GAAP results. Under the terms of the agreement, Merck, through a subsidiary, will acquire all outstanding shares of Caraway with earnout milestones associated with the development of certain pipeline candidates. The Board of Directors of Caraway Therapeutics has approved the transaction. Merck, through its MRL Ventures Fund, has been a shareholder of Caraway Therapeutics since 2018.
|
IMUX | Hot Stocks06:33 EST Immunic receives USPTO allowance for vidofludimus calcium patent - Immunic announced that it has received a Notice of Allowance from the United States Patent and Trademark Office, or USPTO, for patent application 17/992,162, entitled, "Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune Diseases." Specifically, the resulting patent covers dosing regimens associated with lead asset, vidofludimus calcium, or IMU-838, and other salt forms as well as free acid forms for the treatment of multiple sclerosis, or MS, including all regimens tested in the company's MS clinical program. The patent is expected to provide protection into 2038, and, if additional Patent Term Extension is granted, may offer up to 14 years of market exclusivity in the United States upon the drug's potential approval. The patent was previously granted to the company in Japan and certain other countries. This patent adds on the recently received notice of allowance for patent application 17/391,442, claiming treatment of relapsing MS, or RMS, with specific dose strengths.
|
F... | Hot Stocks06:16 EST EU new car registrations up 14.6% in October - In October, the EU car market expanded significantly, with new registrations surging by 14.6% to 855,484 units, said the ACEA. Publicly traded companies in the auto space include Ford (F), General Motors (GM), Honda (HMC), Mercedes-Benz Group (DDAIF), Nissan (NSANY), Stellantis (STLA), Tesla (TSLA), Toyota (TM) and Volkswagen (VWAGY). Reference Link
|
CNTB | Hot Stocks06:08 EST Connect Biopharma's rademikibart shows positive response in atopic dermatitis - Connect Biopharma announced positive topline results from the Stage 2 - maintenance period - of its China pivotal trial evaluating rademikibart's - formerly known as CBP-201 - efficacy and safety in patients with moderate-to-severe atopic dermatitis - AD -. These results follow the previously reported Stage 1 results of the trial, which met all primary and key secondary endpoints. Positive Stage 2 results at Week 52 show the potential of rademikibart as a Q4W treatment for AD. Both Q2W at Q4W dosing regimens, 76%-87% of them maintained their IGA 0/1 and 92% of patients maintained their EASI-75 at Week 52, respectively. All patients that achieved EASI-50 at Week 16 with rademikibart showed continued improvement from Week 16 to Week 52. 21%-28% more patients achieved IGA 0/1, and 11%-16% more patients achieved EASI-75 at Week 52. With respect to quality of life, a greater than or equal to 5-point reduction on the dermatology life quality index is considered clinically important and 93.4% and 90.0% were able to maintain this level at the end of the 52-week study. Treatment with 300 mg Q2W and Q4W of rademikibart was generally well tolerated, and there were no new safety signals. The company separately granted the development and commercial rights of rademikibart in Greater China to Simcere Pharmaceutical, a large pharmaceutical company in China. Simcere will be responsible for rademikibart's new drug application in China, which is still on track for submission by the end of 1Q24. Additionally, Connect Biopharma remains on track for the topline readout next month from its global Phase 2 trial of rademikibart in patients with moderate-to-severe asthma.
|
CNTB | Hot Stocks06:07 EST Connect Biopharma enters license agreement with Simcere Pharmaceutical - Connect Biopharma announced that two of its wholly owned subsidiaries, Connect Biopharma Hong Kong Limited and Suzhou Connect Biopharma Co., Ltd., have entered into an exclusive license and collaboration agreement with Simcere Pharmaceutical Co., Ltd., a subsidiary of Simcere Pharmaceutical Group Ltd, to develop and commercialize Connect Biopharma's rademikibart in Greater China. Under the agreement, Connect Biopharma will complete all of rademikibart's ongoing China clinical trials and related analysis in atopic dermatitis, which is on track for a new drug application submission for AD in China by the end of Q1 2024. Simcere has been granted exclusive rights to develop, manufacture and commercialize rademikibart for all indications in Greater China, including mainland China, Hong Kong, Macau, and Taiwan, while Connect Biopharma retains rights in all other markets. Simcere will be responsible for rademikibart's new drug application for AD in China and will also conduct and be responsible for the costs of all future clinical studies in all additional disease indications for rademikibart in Greater China. According to the terms of the agreement, Connect Biopharma will receive a $21M upfront payment, up to $120M upon achieving certain development and commercial milestones, in addition to royalties up to low double-digit percentages of net sales.
|
BEEM | Hot Stocks06:05 EST Beam Global granted patent for curbside EV charging products - Beam Global has been granted another new patent by the European Patent Office that covers EV Standard, the company's renewably energized streetlight replacement products which provide curbside EV charging. The European Patent Office granted European Patent No. EP3743655 for the company's EV Standard product which is capable of delivering street lighting and meaningful curbside EV charging by combining solar, wind and utility-generated electricity in a bank of Beam Global's proprietary integrated batteries. The patent was issued on July 12, 2023 in the European Patent Bulletin 2031 10.22. Equipped with a high-lumens, low-consumption LED light and a Level II EV charger, the innovative product has been designed to provide a clean and inexpensive EV charging solution which does not require new or upgraded utility-grid circuits, or the trenching, construction, easements, leases and complex permitting required for traditional curbside charging. Most of the energy used for EV charging will come from renewable sources, specifically wind and solar, reducing the carbon impact and the cost of the electricity consumed. To address energy security, the EV Standard can continue to provide EV charging, a source of emergency power and light, during grid outages as well as support and power other vital infrastructure such as IoT connected devices, smart city sensors and environmental monitors.
|
BGNE | Hot Stocks06:03 EST BeiGene, Ensem Therapeutics partner on CDK2 inhibitor - BeiGene and Ensem Therapeutics announced an agreement for BeiGene to acquire an exclusive global license to an Investigational New Drug application-ready oral cyclin-dependent kinase 2 inhibitor. Under the terms of the agreement, Ensem will receive an upfront payment, and will be eligible for additional payments upon the achievement of certain development, regulatory, and commercial milestones, totaling up to $1.33B, in addition to tiered royalties.
|
J | Hot Stocks05:30 EST Jacobs CMS, C&I businesses to merge with Amentum - Amentum announced a definitive agreement to merge with Jacobs' Critical Mission Solutions, or CMS, and Cyber and Intelligence, or C&I, businesses. The combined organization will be a publicly traded company with $13B in revenue and more than 53,000 employees in 83 countries. The transaction was approved by the Jacobs board of directors and is subject to customary closing conditions, including regulatory approvals. The transaction is expected to close in the second half of fiscal year 2024. Upon completion of the deal, John Heller, current CEO of Amentum, will serve as CEO of the combined company and sit on the combined company's board, and Steve Arnette, EVP and president of CMS, will serve as COO. Jacobs' current executive chair Steve Demetriou will become executive chair of the combined company. The board of directors of the combined company will be composed of an equal number of directors appointed by Jacobs and Amentum. Members of the combined company's senior management team will be drawn from both companies and will be announced later as integration planning progresses.
|
STLA | Hot Stocks05:22 EST Stellantis, CATL sign MoU for supply of LFP battery cells and modules in Europe - Stellantis and CATL announced the signing of a non-binding memorandum of understanding, or MoU, for the local supply of LFP battery cells and modules to power Stellantis' electric vehicle production in Europe. To further support Stellantis' aggressive electrification strategy, the two companies are considering the possibility to form a joint venture with equivalent contributions. The MoU outlines a long-term collaboration between CATL and Stellantis on two strategic fronts: building a bold technology roadmap to support Stellantis' cutting-edge battery electric vehicles and identifying opportunities to further strengthen the battery value chain. As part of the Dare Forward 2030 strategic plan, Stellantis announced plans of reaching a 100% passenger car battery electric vehicle, or BEV, sales mix in Europe and a 50% passenger car and light-duty truck BEV sales mix in the United States by 2030. Stellantis is on track to become a carbon net zero corporation by 2038. Stellantis is assembling a roster of partnerships to ensure a stable, low-carbon supply of key materials for its electrified future.
|
MLM | Hot Stocks05:14 EST Martin Marietta to sell South Texas cement business to CRH for $2.1B - Martin Marietta announced that it has entered into a definitive agreement to sell its South Texas cement business and certain of its related concrete operations to CRH Americas Materials, a subsidiary of CRH, for $2.1B in cash. More specifically, the facilities to be divested include the Hunter cement plant in New Braunfels, related cement distribution terminals and 20 concrete plants serving the Austin and San Antonio region. The transaction is expected to close in the first half of 2024, subject to regulatory approvals and other customary closing conditions.
|